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ABSTRACT 
 A quasi experimental study was conducted to “Assess the Effectiveness of 
Structured Teaching Programme on Anticoagulant Drug Compliance among patients 
with Mechanical heart Valve in GKNM Hospital, Coimbatore’’. Objectives: 1.To 
assess the knowledge of patients with mechanical heart valve on anticoagulant drug 
compliance. 2. To compare the pre test and post test knowledge level regarding 
anticoagulant drug compliance among patients with mechanical heart valve. 3. To 
find the association between pre test knowledge score and selected demographic 
variables among patients with mechanical heart valves. Research design: Quasi 
experimental one group pretest-posttest design. Setting: Cardiothoracic wards of G. 
Kuppuswamy Naidu Memorial Hospital, Coimbatore Samples: thirty subjects were 
selected who fulfilled the criteria.Conceptual framework: Modified conceptual 
framework of Context Input Process product model of Daniel Stufflebeam (1983)was 
used. Sampling techniques: Non probability-Convenient sampling technique 
Methods: Structured interview questionnaires were used to assess the demographic 
variables and Knowledge level of patients about Anticoagulant Drug Compliance. Pre 
test was conducted on the 4
th
 day of surgery followed by structured teaching 
programme was administered on an individual basis. Post test level of knowledge was 
assessed on the 8
th
 post operative day or on the day of discharge. Outcomes were 
evaluated by descriptive and inferential statistics. Results: The mean difference of 
levels of knowledge was 7.37, with the combined SD of 3.41 and ‘t’ value of 11.84 
Paired‘t’ test showed that there was a significant difference in pre test and post test 
level of knowledge on anticoagulant drug compliance. This finding indicates that the 
structured teaching programme on anticoagulant drug compliance among patients 
with mechanical heart valve was effective in improving the knowledge level. There is 
mild or negligible association between the level of knowledge on anticoagulant drug 
compliance and demographic variables. Conclusion: The findings of the study proved 
that the education intervention is very effective in improving the knowledge on 
anticoagulant drug compliance among patients with mechanical heart valve. Hence 
the structured teaching program can be implemented by the nurses of cardio thoracic 
units on a regular basis.  
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CHAPTER - I 
INTRODUCTION 
“Our hearts are the core of whom we are, 
Within their deeper essence are to be found all those qualities 
That makes us to feel fully alive and connect us to our profounder humanity.” 
              Dr.Serge Beddington 
 The heart is considered to be the seat of soul, center of courage, treasure of 
love and affection, abode for soul. All these are nearly literary expressions and not far 
away from physiologic truth. In fact, heart is the nonstop pump, which maintains 
circulation of the life sustaining blood to each cell of the body. Heart beat represents 
life and lack of it pronounces death due to cardiovascular disease (Tortora G, J. 
1996). 
 In a healthy human being there are four heart valves. Valves help in 
maintaining proper blood flow by keeping the blood moving smoothly and efficiently 
in the right direction. Heart is made up of four chambers, the upper chambers are 
called right and left atrium, the lower chambers are called right and left ventricle. 
Heart valves are located inside the heart which controls flow of blood from one 
chamber to other. Timely opening and closing of valves allows the heart to pump 
blood smoothly & effectively. Any abnormality in the heart valve will result in 
increased workload of heart allowing blood to flow in opposite direction. Thus the 
four valves of the heart are meant to last through millions of heart beats. 
 A damage or defect in any one of the four heart valves mitral, aortic, tricuspid 
or pulmonary is termed as valvular heart disease. 
  Valvular heart diseases are present either at birth, or occur later in life after an 
infection.  
 The tricuspid and mitral valves control the blood flow between the atria and 
the ventricles. The pulmonary valve controls the blood flow to the lungs and from the 
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heart, and the aortic valve regulates the blood flow between the aorta and heart, and to 
the rest of the body‟s blood vessels. 
 When the valve is stenosed it forces the blood back to the adjacent heart 
chambers, and an incompetent valve allows back flow of blood. To compensate for 
the poor pumping action, the heart muscle thickens, enlarges losing its elasticity and 
efficiency. In some cases, there is a greater tendency of the blood to get pooled with 
the chambers, which increases the risk of pulmonary embolism or stroke. 
 The valvular heart disease severity varies from person to person. There may be 
absence of symptoms, in some cases and it may lead to complications like congestive 
heart failure. Treatment depends upon the type and extent of the disease. Corrective 
surgeries such as heart valve repair or replacement restores or replaces a defective 
heart valve (Hesiler, Jennifer.  2012). 
 In the United States alone there were about 70,000 heart valve replacement 
procedures performed yearly for conditions like mitral valve stenosis secondary to 
rheumatic fever and calcified aortic stenosis in elderly patients (Women‟s Heart 
foundation. 2007). 
 In Europe around 50,000 valve repair and replacement procedures takes place 
annually (Eric G., et al 2005). 
 In heart valve replacement surgery the badly damaged valve is replaced with a 
mechanical valve which is made of metal or plastic, or a bio prosthetic valve derived 
from pig tissue. The damaged valve is removed and the new valve is sewn into place 
(E, Thompson, Gregory. 2010). 
 A tissue valve is made from animal tissue and is replaced in human hearts. 
These are chemically treated for safety and are specially prepared for the human since 
they are weak; they are reinforced and supported with a frame or stent to make the 
valve stronger. When the valves aren‟t reinforced they are known as stent less valves.  
 In the elderly patients these valves last, on an average of 10-15 years. In 
active, younger patients, these valves wear out faster (Aortic valve replacement. 
2007). 
3 
 
 Homograft valve is taken from a human donor. These donor valves are 
replaced in patients with aortic valve defects. These valves remain a better choice for 
pregnant women and children because they do not require a lifelong anticoagulation 
therapy. Durability is same as that of a tissue valve. But are rarely, taken from the 
pulmonic valve of patient‟s.  
 Allograft valves are taken from pig's aortic valve and treated chemically 
before putting it into a human heart. The life span is about 7-15 years. Due to its 
shorter life span it is used only for older age group (Medwiki. 2012). 
 Mechanical valves are made to last lifelong for all patients. They do not wear 
out or break down; its durability is tested using mechanical wear analysis. They offer 
a competitive hemodynamic performance. Mechanical valves allow patients to 
continue the same level of activity throughout their lifetime. 
 In a follow-up study of 2,444 St. Jude Medical mechanical heart valve patients 
for 15 years. Majority of them were able to perform their daily routine activity and 
had a better quality of life as same as that of the general population (SJM 
Worldwide. 2010). 
 Mechanical heart valve patients are more likely to develop blood clots in the 
heart when compared to bio prosthetic heart valve. The blood clots may break loose, 
travel to the brain and cause stroke. A patient who receives a mechanical heart valve 
to treat severe valvular heart disease, needs to take anticoagulants for life time in 
order to prevent clot formation (E. Gregory Thompson. 2010). 
 Anticoagulants are medications that prevent the blood from clotting as 
effectively as the natural processes are also known as blood thinners. 
 Warfarin was the anticoagulant drug prescribed to most of the patients during 
2013.Now the National guidelines recommends using the other anticoagulants such as 
acenocoumarol, phenindione, Dabigatran, apixaban and rivaroxaban which has 
similar side effects of warfarin (Tim., and Jenny. 2013). 
 The common side effect of warfarin is haemorrhage; other complications are 
hypersensitivity or allergic reactions like urticaria and anaphylactic reactions, 
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vasculitis, nausea, vomiting, diarrhoea, taste perversion, abdominal pain, flatulence, 
bloating, rash, dermatitis, pruritus, alopecia, tracheobronchial calcification hepatitis 
and elevated liver enzymes. Cholestatic hepatitis was associated with administration 
of Warfarin sodium and ticlopidine. 
 Thromboembolism and anticoagulant related bleeding are still the most 
common complications in mechanical heart valve patients. Physicians and nurses 
should educate patients about signs and symptoms of bleeding and ask them to report 
immediately if signs and symptoms occurs. Self-management of oral anticoagulants 
helps to prevent the occurrences of   major complications. Studies found that self-
managed oral anticoagulant therapy have a better treatment quality than patients in 
conventional oral anticoagulant therapy (Wysowski ., et al 2007). 
NEED FOR THE STUDY 
 The heart is known as the epicentre of all our new ideas, emotions and 
inspirations. It starts working on the 21
st
 day of conception in mother‟s womb and 
goes on till the last breaths of life. It keeps pumping the blood to the cells of human 
body, spending sleepless nights and days and works throughout life time (Deepak. 
2010). 
 Heart disease is the leading cause of death affecting both women and men. 
According to the World Health Organization nearly 17.5 million lives are lost due to 
heart disease worldwide. The Indian‟s are running fast as American and others. World 
Health Organization estimated that about 60% of the total world‟s cardiac patient will 
be Indians; American‟s are also leading in the list issued by World Health 
Organization (Dipak, 2010). 
 Around 600,000 Americans die due to heart diseases every year, that‟s nearly 
1 in every 4 deaths. (CDC, National Vital Statistics System and the U.S. Census 
Bureau, 2013) 
 Aortic stenosis and mitral regurgitation affects the older population around 4 
to 5 percentages (Wikipedia. 2013).  
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 Between 1964 and 1995, 306 patients underwent valve replacement for left-
sided native (209 patients) or prosthetic (97 patients) valve endocarditis. Mechanical 
valves were implanted in 65 patients, bio prostheses in 221 patients, and homograft‟s 
in 20 patients. (Marc R., et al 2001) 
 A survey was conducted in Great Britain and Ireland by the Society for 
Cardiothoracic Surgery to plan the national requirement for catheter-based 
conventional procedures. Over 5 years 41,227 patients underwent aortic valve surgery 
the in-hospital mortality is 4.1%. The total number increased from 7396 in 2004-2005 
to 9333 in 2008-2009, aortic Stenosis (62.4%-65.1%), octogenarians (13.6%-18.4%), 
high-risk patients (24.6%-27.7%), and for biological valves (65.4%-77.8%). About 
1.2% had permanent cerebrovascular accident, 4.5% had dialysis; 6.6% Underwent 
reoperation due to bleeding. In 2004-2005, 4.4% of mortality is decreased to 3.7% in 
2008-2009. Survival to a mean follow-up of 2.5 years was 89% (Joel., et al 2011). 
 Degenerative valve disease is a growing concern due to the rising amount of 
valve replacement surgeries among the elderly. More than 300,000 prosthetic heart 
valve surgeries were performed each year worldwide, and this rate is projected to 
increase to as many as 850,000 per year by 2050. There is a higher risk of 
thromboembolic events following heart valve surgery; to which anticoagulation and 
antiplatelet therapies are necessary. The drug selection depends on the type of surgery 
performed and the individual risk in any given situation. This article assessed the 
benefit and risks of various therapy schemes as recommended by the Czech, European 
and American Associations of Cardiologists and Cardio surgeons. (Benesov, M. 
2011). 
 Among cardiac valve replacement surgeries, approximately 60 percent receive 
mechanical valves composed of carbon alloys with a bileaflet or tilting disk design. 
About 40 percent patients received bioprosthetic valves, which may be pulmonary 
autografts, homografts, or heterograft‟s (Gerard p., et al 2013). 
 According to the survey conducted by the centre for National Health Statistics, 
about two third of valves were reported as mechanical. About two thirds of both 
mitral and aortic valve implants were reported as mechanical (D.Garver., et al 1995). 
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 Main complications following heart valve surgeries include: bleeding, left and 
right ventricular failure, pulmonary hypertension, conduction abnormalities like 
arrhythmias, infective endocarditis and sudden death (Seiler Christian. 2004). 
 Warfarin is the most commonly prescribed oral anticoagulant therapy in the 
United States. It is effective for the prevention and treatment of thromboembolism in 
the setting of prosthetic heart valves, atrial fibrillation, and myocardial infarction. As 
there was increase in the aging of United States population, the number of patients 
treated with warfarin has continued to increase. In 2004 alone, the number of 
outpatient prescriptions for warfarin was around 31 million. Approximately 4 million 
outpatients in the United States and 7 million patients worldwide are receiving long-
term oral anticoagulant therapy, using warfarin or Coumadin. (Edith A., et al 2011). 
 The primary complication of anticoagulant therapy is bleeding, even when 
maintained within usual therapeutic ranges. The new anticoagulant agents are mainly 
focused on reducing the bleeding risk and managing the bleeding (Mark A., and 
Theodore. 2008). 
 The main goal for treating the patients with oral anticoagulants is to maintain 
the international normalized ratio. This allows the patient to evaluate the plasma 
clotting time with in the therapeutic range. According to the World Health 
Organization, the therapeutic international normalized ratio for aortic valve prosthesis 
is between 2.0 to 3.0 seconds and for mitral valve replacement are between 2.5 to 3.5 
seconds. The main difficulty in treating patients with oral anticoagulant therapy is to 
maintain patient‟s international normalized ratio within these normal limits. 
According to the National and International data 40% to 50% of patients do not meet 
the target value, which leads to an increased risk of bleeding (Rocha. 2010). 
 Prosthetic valve obstruction may be caused by thrombus formation, pannus 
growth, or a combination of these. If the prosthesis is obstructed by pannus, 
thrombolytic therapy will be ineffective, so the valve needs to be replaced. 
Thrombolytic therapy for prosthetic valve obstruction is associated with significant 
risks and is often ineffective. The risk of thromboembolism is around 12 percentage 
and recurrent thrombosis occurs around 11percentage. Patients who develope a large 
clot should undergo for reoperation immediately. Streptokinase and urokinase are the 
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most frequently used thrombolytic agents. Thrombolytic therapy should be stopped by 
24 hours if there is no hemodynamic improvement or atleast within 72 hours. If 
thrombolytic therapy is successful, it should be followed with intravenous heparin 
until warfarin achieves an international normalized ratio of 3 to 4 for aortic prosthetic 
valves and 3.5 to 4.5 for mitral prosthetic valves. If partially successful, thrombolytic 
therapy may be followed by a combination of subcutaneous heparin twice daily plus 
warfarin for a 3-month period (ACC/AHA Practice Guidelines. 1998). 
 Anticoagulation treatment can lead to adverse drug events; the risk is high due 
to the complexity of dosing. These medications ensure patient adherence and monitor 
effects. Anticoagulation education for prescribers independent study found that the 
educational program on the usage of anticoagulants will help to reduce vitamin K 
antagonist related adverse effects (Pernod., et al 2008). 
 If the patients are given adequate education concerning anticoagulation 
therapy, the treatment will clearly be more effective (Doris., et al 2002). 
 An observational study has been done in an emergency department and proved 
that patient education improved adherence to clinical guidelines of treatment with oral 
anticoagulants and prevention of its related bleeding episodes (Temey., et al 2009). 
 Education on the theoretical and pharmaceutical aspects of anticoagulation is a 
fundamental requirement for all patients on anticoagulant therapy. Training on point-
of-care International normalized ratio testing is essential for self-management. The 
contents of the anticoagulation self-management association training course should 
include, basic information on blood coagulation, theoretical principles of individual 
anticoagulation or drug interactions with oral anticoagulants, practical information on 
coagulation monitoring with coagulometers, evaluation of measurements and, dose 
adjustment, signs of bleeding events and thromboembolic events, information on the 
frequency of international normalized ratio determination,  keeping a patient diary,  
travel, nutrition, endocarditis prophylaxis, intramuscular injections, etc (Jack., et al 
2003). 
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STATEMENT OF THE PROBLEM 
 “A Study to Assess the Effectiveness of Structured Teaching Programme on 
Anticoagulant Drug Compliance among Patients with Mechanical heart Valve in 
GKNM Hospital, Coimbatore” 
OBJECTIVES 
1) To assess the knowledge of patients with mechanical heart valve on 
anticoagulant drug compliance. 
2) To compare the pre test and post test knowledge level regarding anticoagulant 
drug compliance among patients with mechanical heart valve. 
3) To find the association between pre test knowledge score and selected 
demographic variables among patients with mechanical heart valves. 
OPERATIONAL DEFINITIONS 
Assess: In this study, assess refers to the statistical measurements of knowledge of 
patients on anticoagulant therapy.  
Effectiveness: It refers to the significant gain in knowledge on anticoagulant drug 
compliance through structured teaching programme. 
Structured teaching programme: It refers to the systematic information provided to 
the patients on anticoagulant drug compliance.  
Anticoagulant: It refers to the medication that inhibits blood coagulation.  
Drug compliance: It refers to the reliability of the patient in using a prescribed 
medication exactly as ordered by the physician, also watching for side effects and 
managing the side effects of anticoagulants. 
Mechanical heart valve: It refers to an artificial heart valve or a device implanted in 
a patient with valvular heart disease. 
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HYPOTHESIS 
H1-There will be a significant difference between the pre test and post test knowledge 
score on anticoagulant drug compliance among patients with mechanical heart valve.  
H2-There will be an association between pre test knowledge score on anticoagulant 
drug compliance with demographic variables of patients with mechanical heart valve. 
ASSUMPTIONS 
 Patients with mechanical heart valve will have less knowledge about 
anticoagulant drug compliance. 
 There will be significant knowledge gain related to anticoagulant drug 
compliance after education through structured teaching programme.  
CONCEPTUAL FRAME WORK 
 A conceptual framework or model is described as a set of broad ideas and 
principles taken from relevant fields of enquiry and used to structure a subsequent 
presentation (Reichel & Ramey, 1987). 
 Conceptual framework helps to frame questions and find suitable literature. It 
is the tool the researcher uses to guide their enquiry. It will guide the researcher in his 
data collection. It enables the researcher to find the links between existing literature 
and his own research goals. 
 The conceptual framework of the present study developed by the investigator 
is based on the Context Input Process Product (CIPP) model of Daniel Stufflebeam 
(1983) 
 The CIPP model is a simple system model applied to programme evaluation. 
Present study aims to assess the effectiveness of structured teaching programme to 
improve the knowledge on anti coagulant drug compliance among patients with 
mechanical heart valve. 
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Context 
 Context evaluation includes examining and describing the context of the 
programme. The context includes conducting needs, determining  the objectives of 
the programme and evaluation. 
 In the present study, context evaluation includes the importance of 
anticoagulant drug compliance among patients with mechanical heart valve at GKNM 
Hospital, Coimbatore. 
Input 
 Input evaluation examines the programme plan of action for programme 
structuring decisions. 
In the present study input includes existing knowledge on anticoagulant drug 
compliance.  
Process 
 Process evaluation includes examining the implementation and monitoring the 
programme‟s performance. Process evaluation helps in implementation of decisions. 
 In the present study, process includes administration of structured teaching 
programme on anticoagulant drug compliance among patients with mechanical heart 
valve in cardio thoracic wards of GKNM Hospital. 
Product 
 Product evaluation includes examining and determining the general and 
specific outcome of the programme. 
 In the present study the product evaluates the post test knowledge level on 
anticoagulant drug compliance. 
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• PROCESS 
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• Structured teaching 
programme on 
anticoagulant drug 
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EVALUATION
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on anticoagulant 
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drug compliance
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• Importance of anti 
coagulant drug 
compliance
Goals Plans
ActionsOutcomes
FIGURE 1.1-Conceptual frame work of CIPP modified and developed from Daniel Stufflebeam (1983) 
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CHAPTER - II 
REVIEW OF LITERATURE 
 Review of literature is a systematic search of published work to gain 
information about a research topic (Polit. 2008).  
An extensive review of literature was done by the investigator to lay a broad 
foundation for the study. 
 The review of the present study is organized in the following headings 
Section A: Literature related to incidence of mechanical heart valve replacement 
surgery 
Section B: Literature related to importance of anticoagulant drug therapy among 
patients with mechanical heart valve  
Section C: Literature related to side effects and management of anticoagulants among 
patients with mechanical heart valve  
Section D: Literature related to nurses role and effectiveness of structured teaching 
programme on anticoagulant drug compliance among patients with mechanical heart 
valve 
SECTION A: LITERATURE RELATED TO INCIDENCE OF MECHANICAL 
HEART VALVE REPLACEMENT SURGERY 
 Maggie., and Thomas. (2011) 15 million people in the United States suffer 
from valvular heart diseases. In 2009 nearly 90,000 patients had undergone valvular 
replacement surgery, patients between 60 to 65 years received mechanical valve due 
to its durability. Patients older than 60 to 65 years received biological valve, some 
characters that have been considered like patient co-morbidities, need for 
anticoagulants, patients anxiety, expectations for their life style and quality of life 
were incorporated in valve selection. 
  Frank., et al (2011) conducted a retrospective study on the  outcome of 114 
children who had undergone mechanical valve replacement in West Africa. 
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57.9%were female; of them 13 (11.4%) were non-Ghanaian West Africans who were 
on prolonged illness. Within one year of diagnosis less than 20% were able to afford 
for surgery. 
 Rao., et al (2011) conducted a review of literature to justify the exclusive use 
of either mechanical or tissue prostheses in the mitral position. A five year follow-up 
from the Toronto General Hospital was included and reviewed. Both studies 
concluded that there was no significant advantage for the use of either type of valve 
based upon freedom from thromboembolism, anticoagulant-related hemorrhage and 
valve-related mortality. The results suggested the preferential use of mechanical 
valves during mitral valve replacement was based on their durability and a consequent 
lesser need for reoperation.  
 Prendergast., and Tornos. (2010) stated that infective endocarditis is still a 
dangerous condition with unchanging incidence and the mortality rate of about 30% 
in 1 year. During acute infection 25% to 50% of cases required surgery as a life 
saving measure, nearly 20% to 40% of patients requires surgery during the 
convalescence stage. Valve replacement surgery has an established role in the 
management of infective endocarditis across wide range of patients. 
 Ozeren M., et al (2004) conducted a study to find the clinical results of ATS 
prosthetic valve, from September 1998 to July 2000. 199 patients were implanted with 
240 ATS valve prostheses, of them 88 patient had mitral, 70 patient had aortic, and 41 
patient had double valve replacements respectively. The outcome in 240 implants 
showed the ATS valves have a decreased incidence of complications, and is safe to 
provide excellent hemodynamic performance. 
 Ogendo. (2000) conducted a combined retrospective and prospective study 
from 1973 to 1977 in patients attending the cardiothoracic outpatient clinic of 
National Hospital at Kenyatta. Study found that the overall follow up rate was 476.3 
patients per years and the incidence of morbidity rate was 2.73% patient per year. 
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SECTION B: LITERATURE RELATED TO IMPORTANCE OF 
ANTICOAGULANT DRUG THERAPY FOR MECHANICAL HEART VALVE 
PATIENTS.  
 Ronelle. (2013) had a debate on the duration of anticoagulants for patients 
receiving bioprosthetic aortic valves. Aspirin was recommended as the drug of choice 
for thromboembolic action by the American College of Chest Physicians. The 
American Heart Association recommended a 3-month course of treatment with 
warfarin plus aspirin. An epidemiologic findings by Denmark and Merie states that 
patients with bioprosthetic implants have to remain on anticoagulants for 6 months 
after heart valve replacement surgery. Their findings provide evidence that the early 
discontinuation of anticoagulants after mechanical valve implantation was associated 
with increased cardiovascular death.  
 Massel., & Little. (2013) conducted a study to assess the efficacy and safety 
of combined antiplatelet and oral anticoagulant therapy versus oral anticoagulation 
monotherapy in patients with prosthetic heart valves. Study found that adding 
antiplatelet therapy, either low-dose aspirin or dipyridamole, to oral anticoagulants 
decreased the risk for systemic embolism or death. In antiplatelet therapy risk for 
bleeding is increased but low-dose aspirin appears to be similar to higher-dose aspirin 
and dipyridamole was found to be safe and effective in patients with prosthetic heart 
valves.  
 Gerard, P, Aurigemma. (2013) discussed about the antithrombotic therapy 
among prosthetic heart valve patients. The major complications in patients with 
prosthetic heart valves include hemolysis, paravalvular leak and endocarditis. The 
main issue while managing the patients with mechanical heart valve is antithrombotic 
therapy. It is prescribed mainly to prevent thromboembolism and valve thrombosis. 
 Dr.Avinashdal. (2012) stated that, oral anticoagulants are the drugs that are 
used in patients to prevent blood clotting (blood thinners). These medicines are useful 
in patients who had undergone valve replacements and in some cases with coronary 
and vascular diseases. A mechanical heart valve replacement patient has to use these 
medicines life-long. 
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 Wikipedia. (2011) two types of valves can be used for valve replacement; 
they are mechanical and tissue valves. Nowadays mechanical valves last lifelong. All 
mechanical heart valves require lifelong anticoagulant treatment. Anticoagulation is 
the process of thinning the blood. 
 USC Cardiothoracic Surgery. (2010) stated that mechanical valves are 
created from man-made materials. Lifelong anticoagulation therapy is needed while 
using these type of valves. Anticoagulant medication prevents the blood clots from 
forming in or around the valve. 
 Marieke., et al (2009) done a prospective study on 4202 patients with 
mechanical heart valves, to find the optimal level of oral anticoagulant therapy for the 
prevention of arterial thrombosis, atrial fibrillation, or myocardial infarction. Study 
found that international normalized ratio of 3.5 after myocardial infarction and 3.0 for 
patients with mechanical heart valve had atrial fibrillation as a starting point in 
clinical trials. 
 Goldhaber, Samuel Z. (2006) done a study to minimize the delay in 
achieving therapeutic anticoagulation and revealed that mechanical heart valve 
patients require anticoagulant therapy to prevent valve-associated thromboembolic 
stroke and thrombosis. Oral vitamin K antagonists such as warfarin do not act 
immediately. They require at least 5 days to achieve a therapeutic effect. 
 Henry, Bussey. (2004) presented a paper in the conference of Duke 
University Clinical Research Institute, to discuss the options for mechanical heart 
valve patients for improving antithrombotic outcomes. Author explained that using 
warfarin is effective and safe therapy. Although single antiplatelet therapy is 
considered as an inadequate therapy comparing to combine antiplatelet therapy which 
offer platelet-inhibiting mechanisms in mechanical heart valve patients. 
 Little., et al (2003) a comparative study was done to assess the safety and 
effectiveness of antiplatelet therapy with oral anticoagulation among patients with 
prosthetic heart valves. The reference lists of individual reports, consensus statements, 
review articles and meta-analyses. Finding suggested that adding antiplatelet therapy, 
either low-dose aspirin or dipyridamole, to oral anticoagulation will decrease the risk 
of systemic embolism or death among patients with prosthetic heart valves. 
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 Eric., et al (2001) conducted a prospective follow-up after Medtronic hall 
valve replacement; to assess the effect of anticoagulation control on long-term 
survival. The multivariate analysis found that high anticoagulation variability is the 
most important independent predictor of reduced survival after valve replacement 
with a mechanical valve. Better anticoagulation control had improved the survival. 
 Christa., et al (2000) stated that the indications for oral anticoagulation 
treatment has extended over the past 10 years. Studies on non-valvular atrial 
fibrillation, and valvular heart surgery leads to an increased number of patients 
treated. 64 000 valve operations were performed across Europe in 1997; in two thirds 
surgeries mechanical prostheses were used, which needs lifelong oral anticoagulant 
treatment. 
SECTION C: LITERATURE RELATED TO SIDE EFFECTS AND 
MANAGEMENT OF ANTICOAGULANTS AMONG PATIENTS WITH 
MECHANICAL HEART VALVE . 
 Teresa, Marino,. (2013) states that warfarin is more effect than 
unfractionated heparin for pregnant women with mechanical valves as a 
thromboembolic prophylaxis. During the first trimester of pregnancy warfarin therapy 
may cause a substantial increase in fetal anomalies. Anticoagulation with any agent 
had an increased incidence of prematurity, fetal wastage, and low birth weight. 
 Anna., and Robert. (2013) conducted a prospective study. Patients after 
aortic or mitral mechanical valve replacement were selected, to evaluate the 
pharmacokinetics and safety of oral dabigatran and etexilate. Patients were selected 
and assigned to receive warfarin or dabigatran in 2:1 ratio with dabigatran renal dose 
at 150 to 300 mg twice daily in order to achieve plasma trough of at least 50mg per 
millilitre, to prevent valve thrombosis. Warfarin was dosed to achieve international 
normalized ratio 2.0-3.0 or 2.5-3.5, depending on patients' thromboembolic risk 
.Study revealed that comparing to warfarin, dabigatran had an increased risk of 
thromboembolic events and bleeding in patients with mechanical heart valves. 
 Haibo., et al (2012) conducted a correlative study among 1,658 Chinese 
patients after valve replacement surgery with an aim to find the correlation between 
intensity of anticoagulant therapy and thromboembolism or hemorrhagic 
17 
 
complications, follow up of 1,508 patients after 1-61 months were done and found 
that  the incidence rate of anticoagulation-related hemorrhage was 2.02% patient per 
years. The incidence rate of anticoagulation-related thromboembolism was only 1.17 
out of 100 patient per years. The incidence rate of total complications was about 
3.24% patient per years. Study revealed that low anticoagulant strategy can efficiently 
prevent hemorrhage and thrombosis complications.  
 Mathew., and Kumar (2010) reported that patients on warfarin who 
experience severe bleeding are reversed by stopping the warfarin therapy, 
administering fresh frozen plasma or prothrombin complex concentrates and 
administering vitamin K prevented further bleeding. Vitamin K is often slow to bring 
the international normalized ratio within normal range, because the time needed for 
hepatic synthesis of vitamin K was dependend on the coagulation factors. The delay 
in optimal reversal, combined therapy by using vitamin K with fresh frozen plasma or 
prothrombin complex concentrates is recommended.  
 Erica., et al (2009) conducted a systemic review on mechanical heart valve 
patients taking oral anticoagulation therapy having intracranial haemorrhage. The 
study found that restarting oral anticoagulant therapy few days after the occurrence of 
cerebral haemorrhage or stopping anticoagulant therapy  indirectly for few days are 
both safe. 
 Crowther., and warkentin. (2008) presented a plan of management for 
anticoagulation induced bleeding. Heparin and coumarin are inexpensive, effective, 
widely available and have specific antidotes but problematic because they need 
careful monitoring. Warfarin had delayed onset of action and had a narrow 
therapeutic window also interacts with many medications, in certain settings it is 
paradoxically prothrombotic. Heparin requires monitoring for its therapeutic effect 
and can also cause thrombosis.  
 D.Puri., et al (2008) done a comparative analysis of various anticoagulation 
protocols utilized in an institution, to find the early anticoagulation effect from the 
first post operative day. Three groups of patients were selected according to the type 
of anticoagulant. The patients who received oral anticoagulation from the first 
postoperative day were grouped as A; Patients who received oral anticoagulation 
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along with low-molecular weight heparin were grouped as Group B; and the patients 
who received unfractionated heparin along with anticoagulants within 12 hours after 
surgery as group C. The study concluded that treatment with early oral 
anticoagulation therapy provides optimum anticoagulation effect with minimum 
complications. 
 According to Christian Seiler. (2004) by administering vitamin K and by 
withholding warfarin excessive anticoagulation can be managed. Bleeding can be 
managed by transfusing fresh frozen plasma. The major causes for morbidity and 
mortality are haemorrhagic and thrombotic complications. Thrombosis occurs in 1–
3% cases annually and thromboembolic events in 0.7% of cases. The annual risk of 
bleeding is 2.7%. Mortality was higher in patients with bleeding complications. These 
complications may vary with increasing age of patient with the valve prosthesis.  The 
incidence of thromboembolic events with tilting disk, bileaflet and ball cage 
prostheses is estimated to be 2.5%, 0.7%, and 0.5% per year, respectively. 
 According to the American Society for Gastrointestinal Endoscopy. (2002) 
the most common site of significant bleeding in patients receiving oral 
anticoagulation therapy is the gastrointestinal tract. A history of prior gastrointestinal 
bleeding, but not a history of peptic ulcer disease is associated with an increased risk 
of major gastrointestinal hemorrhage during warfarin therapy (30% at 3 years versus 
5% in those with no prior bleeding history).The risk of gastrointestinal bleeding is 
increased when the international normalized ratio  is above the therapeutic range. 
 Levine., et al (2001) conducted a review to find the incidence of hemorrhage 
in patients who were receiving oral anticoagulants and heparin. Relevant articles were 
taken from symposia of the American college of chest physicians. The study revealed 
that the annual rate of spinal bleeding and intracranial bleeding was 0.57%.The major 
extra cranial bleeding was 2.1% per year. 
  G Montalescot., et al (2000) conducted a comparative non randomized study 
in 208 patients to find the effect of low molecular weight heparin and unfractionated 
heparin after mechanical heart valve replacement. One group was treated with 
unfractionated heparin and found that 27% of patient had activated partial 
thromboplastin time above 1.5 times of control, but 62% were over anticoagulated 
19 
 
two major bleedings occurred and one stroke occurred. Other group is treated with 
low molecular weight heparin and found that it provided adequate anticoagulation and 
appears feasible. 
 Cannegieter., et al (1995) done a study to determine the optimal intensity of 
oral anticoagulant therapy for patients with mechanical heart valves. Optimal intensity 
was determined at different levels of anticoagulation, by calculating the incidence of 
complications, 1608 patients were followed for 6475 patient-years. 43 patients‟ had 
cerebral embolism, peripheral embolism in 2patients, intracranial and spinal bleeding 
had occurred in 36 patients and major extra cranial bleeding in 128patients. The 
incidence of both complications was low, while achieving the international 
normalized ratio between 2.5 and 4.9, to achieve the level of anticoagulation, a target 
international normalized ratio of 3.0 to 4.0 is recommended. 
SECTION D: LITERATURE RELATED TO NURSES ROLE AND 
EFFECTIVENESS OF STRUCTURED TEACHING PROGRAMMAE ON 
ANTICOAGULANT DRUG COMPLIANCE AMONG PATIENTS WITH 
MECHANICAL VALVE. 
 New Orleans. (2013) conducted a study to assess 1738 patients‟ knowledge of 
anticoagulation and its association with clinical characteristics. Study found that 
younger and more educated patients were more likely to pass the oral anticoagulation 
knowledge and further research is needed to assess the relationship between 
anticoagulation knowledge, international normalized ratio control and adverse clinical 
outcomes. 
 Verret, L., et al (2013) had done a randomized study in 114 patients of age 
18-75yrs, who had received warfarin for at least six months at a specialized 
anticoagulation clinic. The quality of life and anticoagulation control was compared 
with a physician-led specialized anticoagulation clinic and pharmacist-led warfarin 
patient self-management program in a Tertiary academic medical care center. 58 
patients attended an educational session on anticoagulation given by a pharmacist and 
another 56 patients in controlled group had undergone management at the 
anticoagulation clinic. Knowledge was assessed using questionnaire at the beginning 
and end of the study. By calculating the time spent in therapeutic range quality of 
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anticoagulation control was evaluated. The study found that there is an improvement 
in the quality of life of patients who received self management warfarin program led 
by pharmacists. 
 Mair., et al (2012) conducted a retrospective follow-up from 1993 to 1998 on 
patients who received mechanical heart valve prostheses on long-term self-
management of anticoagulation therapy. Outside trial conditions was hypothesized 
and found that self-management of oral anticoagulant improves long-term outcome 
and treatment quality.  
 Syed, R., et al (2011) conducted a cross-sectional study in156 patients 
attending physician- and pharmacist-managed anticoagulation clinics, from 2008 to 
2010.To assess the factors affecting warfarin-related knowledge and international 
normalized ratio control .No significant differences were found between medication 
therapy adherence clinic and non- medication therapy adherence clinic. Medication 
therapy adherence clinic patients were found to have better international normalized 
ratio control compared to non- medication therapy adherence clinic patients. The 
study concluded that a combined cooperation between physicians, nurses and 
pharmacists, should exist to achieve desired therapeutic outcomes.  
 Moore, Dana. (2011) states that patients on anticoagulant therapy must be 
educated about the drug-specific information, risk for bleeding, how to monitor 
bleeding, and management for bleeding if it occured. 
 Heisler., et al (2011) conducted a study on oral anticoagulation knowledge 
and international normalized ratio goal attainment of patients attaining in an 
anticoagulation clinic in a Veterans Affairs Medical Center.10 previous international 
normalized ratio control values with in goal range were collected and compared. The 
study showed that out of 29 questions, 74.1% of patients on long-term warfarin 
therapy got 21 correct answers. The anticoagulation knowledge assessment instrument 
shows that, there was no significant relationship between international normalized 
ratio control and patient warfarin knowledge. 
 Gilles., et al (2008) conducted a prospective multi center open randomized 
study to evaluate the effect of patient education about oral anticoagulation therapy in 
reducing recurrent thrombotic and hemorrhagic complications. In the intervention, 
21 
 
one group had a specific oral anticoagulation treatment educational program and was 
compared with a control group. Study shows that patient education using an 
educational program had reduced vitamin k agonist-related adverse event rates. 
 Zeolla, MM., et al (2006) conducted a study to develop and validate an 
instrument for assessing patients knowledge regarding oral anticoagulation therapy. 
The oral anticoagulation knowledge test was conducted to the subjects who were on 
warfarin and who were not on warfarin. After 2-3 months of initial assessment a 
subgroup of warfarin subjects were retested to assess test- retest reliability. Patients 
taking warfarin were scored higher than the patients who are not on warfarin. Thus 
the findings demonstrated that the oral anticoagulation knowledge test is a valid, brief, 
and reliable knowledge assessment instrument that can be a useful tool for research 
and clinical practice to augment patient education programs. 
 Fang., et al (2006) conducted a survey on 179 patients taking warfarin in an 
anticoagulation clinic. Patients were interviewed and administered the test of 
functional health literacy to find the association between health literacy, warfarin 
knowledge, warfarin control and adherence. The study showed that about 57.0% of 
patients had high self-reported adherence to therapy, they reported that for more than 
3 months they had not missed a dose. Study proved that limited health literacy was 
not significantly associated with self-reported adherence to adjusted or unadjusted 
analyses. 
 Nadar., et al (2003) conduct a cross-sectional questionnaire survey was done 
in three Birmingham teaching hospitals among 180 patients who were attending 
anticoagulation clinics. The study revealed that knowledge and perceptions of 
antithrombotic therapy differ between ethnic groups in the United Kingdom. Study 
showed that there is no significant difference between the groups. 
 Elaine., et al (2003) conducted a study to evaluate patient‟s warfarin 
knowledge and its relationship to control anticoagulation. Patient‟s knowledge were 
tested by using 9 questions. Score was calculated for each patient. Sixty patients had 
better knowledge because they had read the information booklet on warfarin than 
those who had not. There was a positive correlation between patient‟s warfarin 
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knowledge and the number of international normalized ratio values and also found 
that patient‟s warfarin knowledge was poor. 
 Sawicki, T. (1999) conducted a self-management program for patients 
receiving oral anticoagulation to investigate the control measures of treatment-related 
quality of life. Patients were grouped based on the treatment, teaching program and 
international normalized ratio self-monitoring. It was found that an anticoagulation 
education program with self-management of anticoagulation therapy results in 
improved accuracy of anticoagulation control and treatment-related quality-of-life 
measures. 
  Stone, S., et al (1989) done a study to assess the effectiveness of video tape 
patient education and personalized patient education for anticoagulant therapy. Both 
groups had significantly higher knowledge score after instruction, but videotape 
instruction required substantially less nursing time. The study found that videotape 
teaching is an effective, alternative and well-accepted form of patient education which 
requires less personnel time. 
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CHAPTER - III 
METHODOLOGY 
       Research methodology is a way to solve the research problem systematically. It 
deals with defining the problem, formulation of hypothesis, methods adopted for data 
collection and statistical techniques used for analysing the data with logical reason 
behind it. 
FIGURE3:1 - SCHEMATIC REPRESENTATION OF THE RESEARCH 
METHODOLOGY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Research Approach 
Quantitative research approach 
 
Research Design 
Quasi experimental one group pretest-posttest design 
 
Setting 
Cardiothoracic wards of GKNM Hospital 
Population 
Patients with mechanical heart valve prescribed with anticoagulants 
 
Sample Size (n) =30     
 
Sampling Technique 
Non probability-convenient sampling technique 
Data Collection Process 
Demographic data, assessment of knowledge using structured 
interview questionnaire 
 
Data Analysis  
Descriptive and inferential statistics 
Intervention 
Structured teaching programme on anticoagulant drug compliance 
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RESEARCH APPROACH 
 The Research approach selected was the Quantitative research approach. This 
approach was used to assess the effectiveness of structured teaching programme on 
anticoagulant drug compliance among patients with mechanical heart valve. 
RESEARCH DESIGN 
 The research design provides an overall plan for conducting the study. Quasi 
experimental one group pre test post test design was selected for this study. 
Demographic data and knowledge on anticoagulant drug compliance were 
assessed during the pre test. The pre test scores were used as a base to compare the 
post test scores. The post test score represented the effectiveness of structured 
teaching programme on anticoagulant drug compliance. 
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    O1        X          O2 
 
  
 
 
    
O1=Pre test       X=Intervention                          O2=Post test 
 
PRE TEST 
 Assessment of demographic 
variables  
 Assessment of knowledge 
level on anticoagulant drug 
compliance among patients 
with mechanical heart valve.  
 
POST TEST 
 Assessment of knowledge 
gained on the anticoagulation 
drug compliance among 
patients with mechanical heart 
valve.  
 
 
INTERVENTION 
Structured teaching 
programme 
 
FIGURE 3.2 - SCHEMATIC REPRESENTATION OF RESEARCH DESIGN 
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VARIABLES 
Influencing variable : Age, sex, educational status, occupation, and Previous 
knowledge about anticoagulants 
Dependent variable  : Knowledge of patients with mechanical heart valve, on 
anticoagulant drug compliance. 
Independent variable : Structured teaching programme on anticoagulant drug 
compliance. 
Extraneous variable : Previous knowledge about anticoagulants and information 
received from health care professionals. 
FIGURE 3.3 - SCHEMATIC REPRESENTATION OF VARIABLES 
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SETTING OF THE STUDY 
 The study was conducted in the cardiothoracic wards of G. Kuppuswamy 
Naidu Memorial Hospital, Coimbatore which is a super speciality tertiary care centre. 
POPULATION 
The population comprised of patients with prosthetic heart valve on 
anticoagulant drug therapy during the study period. 
SAMPLE SIZE  
 The sample size was determined, using Mahajans formula 
Sample size (n) = 4Pq  
         L
2
 
P = Percentage of population   P = (27/234)*100 = 12 % 
q = 100 – P     q = 100 – 12 = 88 
L = Allowable error    L = 12  
 Sample size (n) = 4Pq        = (4*12*88)/144 = 30 
                    L
2 
 According to this formula, it
 
was decided to select 30 samples for the study 
SAMPLING TECHINIQUE 
 Non probability convenient sampling technique was adopted for the study. 
SAMPLING CRITERIA 
Inclusion criteria 
 Patients with prosthetic heart valve on anticoagulant therapy. 
 Patients who were willing to participate in the study. 
 Patients who can understand and communicate in Tamil or English  
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Exclusion criteria 
 Patient who are hemodynamically  unstable  
 Patient who develop complications after prosthetic valve replacement surgery. 
DESCRIPTION OF THE TOOL 
  The data collection tool consisted of two sections. 
Section A: Demographic data 
It comprised of demographic variables of the subjects which includes age, sex, 
education, religion, type of family, occupation, family income, marital status, 
previous history of surgery and awareness of anticoagulant drug prescribed. 
Section B: Structured interview questionnaire  
  It comprised of 20 questions under eight separate sub headings to assess the 
knowledge regarding anticoagulant drug therapy for patients with mechanical heart 
valve. The data was collected by interview method; the collected data was categorized 
according to the selected aspect. 
 The scoring pattern is as follows. Each “correct” answer was given a score of 
one and a score of zero was given for the “wrong” answer. The maximum score was 
20.The level of knowledge was categorized based on the scoring as follows; as 0-10 
Inadequate Knowledge, 11-15 Moderate Knowledge and 16-20 score as adequate 
knowledge. 
DESCRIPTION OF THE INTERVENTION 
After shifting the patients from cardio thoracic intensive care unit to cardio 
thoracic wards, on the 4
th
 post operative day following valve replacement surgery, the 
patients were interviewed using the structured interview questionnaire and 
demographic data, to assess their knowledge on anticoagulant drug compliance. After 
the pre test, structured teaching programme on anticoagulant drug compliance was 
given. The post-test was performed on the day of discharge (8
th
 day of surgery) to 
assess the level of knowledge on anticoagulant drug compliance. 
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FIGURE: 3.4 - SCHEMATIC REPRESENTATION OF INTERVENTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VALIDITY 
The tool was submitted for content validity to experts in the field of cardio 
thoracic surgery and medical surgical nursing in and around Coimbatore. The 
translated Tamil version of the tool was validated by Tamil experts. Based on their 
suggestions and recommendations, the tool was finalized. 
INTERVENTION 
• Structured teaching programme on anticoagulant drug 
compliance for 30 minutes regarding 
 Normal heart and its function 
 Artificial valves 
 Blood coagulation 
 Laboratory investigations 
 Anticoagulants 
 Storage 
 Dosage 
 Symptoms of lower dose and overdose 
 First aid measures for minor complications 
 Measures to decrease the risk of bleeding 
 Guidelines to improve the medicine performance 
 Prosthetic heart valve infection 
 Life style modification 
 
PRE TEST KNOWLEDGE ASSESSMENT ON 
ANTICOAGULANT DRUG COMPLIANCE 
 Demographic data  
 Structured interview questionnaire 
POST TEST KNOWLEDGE ASSESSMENT ON 
ANTICOAGULANT DRUG COMPLIANCE 
 Structured interview questionnaire 
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RELIABILITY 
 Reliability of the research instrument is defined as the extent to which the 
instrument yields the same results on repeated measures. It is concerned with 
consistency, accuracy, precision, stability, equivalence and homogeneity (Kothari 
CR., 1996). 
 The reliability of the tool was determined using the Spearman Brown‟s Split-
Half technique which showed r = 0.949 for structured knowledge questionnaire. 
Hence the tool was found highly reliable. 
Reliability was computed using the following equation, 
                r =     (X-X) (Y-Y)       
                               (X-X) 2 x (Y-Y) 2 
ETHICAL CONSENT 
 The ethical consent was obtained from the research committee of GKNM 
Hospital, Coimbatore. Informed consent was obtained from the study participants. 
Confidentiality was maintained throughout the study. 
PILOT STUDY 
 Pilot study was conducted in the cardiothoracic wards of G. Kuppuswamy 
Naidu Memorial Hospital, Coimbatore, for a period of two weeks (15.07.2013 - 
26.07.13) from 8am to 5pm.Six patients were selected by convenient sampling 
technique. After obtaining the informed consent the demographic datas were collected 
and structured interview questionnaire were used to collect data. Structured teaching 
programme on anticoagulant drug compliance was administered to the study 
participants, the results showed that the structured teaching programme was effective 
in increasing the knowledge level of patients on anticoagulant drug compliance. Upon 
completion of the pilot study, the feasibility & practicability of the study was 
assessed. Based on the pilot study results necessary changes were made in the tool. 
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DATA COLLECTION PROCEDURE 
 The data collection period was for four weeks. Data was collected every day 
from 29.07.13 - 24.08.13.The samples selected were given a self introduction and 
then an oral consent was obtained from them. The participants were assured about 
confidentiality of the data to be collected and were told that it will be used only for 
research purpose. The pre test knowledge questionnaire and demographic datas were 
administered on the 4
th
 day of surgery, followed by the structured teaching 
programme. It was followed by an interactive session with the patient and family 
members so as to clarify their queries and furnish them with adequate explanations. 
Post test level of knowledge was assessed on the 8
th
 post operative day or on the day 
of discharge. 
PLAN FOR DATA ANALYSIS 
  The data collected from subjects were compiled and analyzed using 
descriptive and inferential statistics. 
1. Descriptive statistics: Frequency, standard deviation, mean and mean percentage 
were used to describe patients demographic variables. 
2. Inferential statistics:  Paired„t‟ test was used to compare the pre test and post test 
knowledge scores. Chi-square test was used to find out the association between 
selected demographic variable and knowledge scores. 
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CHAPTER - IV 
ANALYSIS AND INTERPRETATION 
 Analysis is defined as the process of systematically applying statistical and 
logical techniques to describe, summarize and compare the data (Suresh K, Sharma. 
2011). 
 This chapter deals with the analysis and interpretation of data collected from 
30 samples after mechanical valve replacement surgery, and on anticoagulant drug 
therapy, to assess the effectiveness of structured teaching programme on 
anticoagulant drug compliance among patients with mechanical heart valve. The 
findings are based on descriptive and inferential statistical analysis and it is tabulated 
and described as follows: 
Table 4.1:  Distribution of patients based on demographic variables 
Table 4.2: Distribution of pre test level of knowledge on anticoagulant drug 
compliance among patients with mechanical heart valve 
Table 4.3: Distribution of post test level of knowledge on anticoagulant drug 
compliance among patients with mechanical heart valve 
Table 4.4: Distribution of pre test and post test knowledge scores on anticoagulant 
drug compliance among patients with mechanical heart valve 
Table 4.5:   Association between pre test knowledge score and selected demographic 
variables 
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TABLE 4.1 DISTRIBUTION OF PATIENTS BASED ON DEMOGRAPHIC 
VARIABLES. 
        n=30 
SI 
No 
Demographic variables 
Frequency 
(f) 
Percentage 
(%) 
1 Age 
Below 30 yrs 
a) 31-40 
b) 41 -50 
c) 51-60 
5 
11 
9 
5 
16.67 
36.67 
30 
16.67 
2 Sex 
a) Male 
b) Female 
10 
20 
33 
67 
3 Education 
a) Illiterate 
b) Primary 
c) Secondary 
d) Higher secondary 
e) Under graduate 
f) Post graduate 
8 
4 
11 
3 
2 
2 
26.67 
13.33 
36.67 
10 
6.67 
6.67 
4 Religion 
a) Hindu 
b) Muslim 
28 
2 
93 
7 
5 Type of family 
a) Nuclear family 
b) Joint family 
22 
8 
73 
27 
6 Occupation 
a) Unemployment 
b) Agriculture 
c) Government 
d) Private 
e) Others 
16 
4 
1 
7 
2 
53.33 
13.33 
3.33 
23.33 
6.67 
7 Family income 
a) Less than 10,000 
b) 10,001-20,000 
25 
5 
83 
17 
 
8 
Marital status 
a) Married 
b) Unmarried 
26 
4 
87 
13 
9 
Previous history of any 
surgery 
a) Yes 
b) No 
19 
11 
63 
37 
34 
10 
Awareness of the 
anticoagulant drug 
prescribed 
a) Yes 
b) No 
3 
27 
10 
90 
Table (4.1) reveals the distribution of demographic variables.  
Age: Out of 30 patients 5(16.67%) were below the age of 30yrs and 51-60yrs of age 
group. 11(36.67%) of them were between the age group of 31-40yrs. 9(30%) of them 
were between the age group of 41-50yrs. 
 Sex: Majority of patients were females20 (i.e)(67%) and 10 (i.e) (33%) were males 
Education: Considering the patients educational level, 8(26.67%) were illiterate. 
4(13.33%) had primary level education.11 (37%) had secondary school level 
education, and 3(10%) had higher secondary level education. 2(6.67%) had under 
graduate and post graduate education. 
Religion: With respect to religion, majority of them were Hindus i.e., 28(93%) and 
2(7%) were Muslims. 
Family: Majority of patients (i.e)22(73%) belong to nuclear family and 8(27%) 
belong to joint family.  
Occupation: 16(53%) of patients were unemployed. 4(13.33%) belong to agriculture 
group.1 (3.33%) were government employees and 23(33%) were private employees. 
2(6.67%) belongs to other group 
Income: Among 30 patients 25(83%) had an income of less than Rs.10, 000 per 
month and 5(17%) had Rs10, 001-20,000 income per month. 
Marital status: Majority 26(87%) of them were married and 4(13%) were unmarried. 
Previous history of surgery: 19(63%) had previous history of surgery, and 1(37%) 
had history of surgery. 
Awareness of the anticoagulant drug prescribed: Only 3(10%) were aware of the 
anticoagulant drug prescribed and 27(90%) of the patients were not aware of the 
anticoagulant drug prescribed.                   .
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FIGURE: 4.1 DISTRIBUTION OF ACCORDING TO  AGE 
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FIGURE: 4.2 DISTRIBUTION OF PATIENTS BASED ON THE EDUCATIONAL STATUS 
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FIGURE: 4.3 DISTRIBUTION OF PATIENTS BASED ON THEIR OCCUPATION 
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FIGURE : 4.4 DISTRIBUTION OF PATIENTS ACCORDING TO THEIR  PREVIOUS EXPERIENCE OF  
SURGERY 
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FIGURE: 4.5 DISTRIBUTION OF PATIENTS ACCORDING TO THEIR AWARENESS ON ANTICOAGULANT DRUG THERAPY 
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TABLE 4.2 DISTRIBUTION OF PRE TEST LEVEL OF KNOWLEDGE ON 
ANTICOAGULANT DRUG COMPLIANCE AMONG PATIENTS WITH 
MECHANICAL HEART VALVE. 
      n = 30 
Level of 
knowledge 
Scores 
 
Pre test 
Mean SD 
Frequency Percentage 
Adequate 
knowledge  
16-20 0 0 
9.93 2.71 
Moderate 
knowledge  
11-15 
11 37 
Inadequate 
knowledge 
1-10 
19 63 
            
TABLE (4.2) shows the pre test level of knowledge on anticoagulant drug 
compliance among patients with mechanical heart valve. The results showed that in 
pre test 11(37%) patients had moderate knowledge, 19 (63%) patients had inadequate 
knowledge and none of them had adequate knowledge. The mean score was 9.93 with 
a SD of 2.71. 
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TABLE 4.3 DISTRIBUTION OF POST TEST LEVEL OF KNOWLEDGE ON 
ANTICOAGULANT DRUG COMPLIANCE AMONG PATIENTS WITH 
MECHANICAL HEART VALVE 
       n=30 
Level of 
knowledge 
Scores 
Post test 
Mean SD 
Frequency Percentage 
Adequate 
knowledge 
16-20 
25 83.33 
17.3   1.9 
Moderate 
knowledge 
11-15 
5 6.67 
Inadequate 
knowledge  
1-10 
0 0 
 
TABLE (4.3) shows the post test level of knowledge on anticoagulant drug 
compliance among patients with mechanical heart valve. The results showed that in 
post test 25(83.33%) patients had adequate knowledge, 5(6.67%) patients had 
moderate knowledge and none of the patients had inadequate knowledge. The post 
test mean score was 17.3 with a SD of 1.9. 
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TABLE 4.4  DISTRIBUTION OF PRE TEST AND POST TEST KNOWLEDGE 
SCORES ON ANTICOAGULANT DRUG COMPLIANCE AMONG 
PATIENTS WITH MECHANICAL HEART VALVE 
       n=30   
Group 
Mean of the 
differences 
SD 
Paired 
„t‟ value 
df 
Table 
value 
(5%) 
Significant /  
Non 
significant 
 
Pre test 
 7.37 
 
3.41 
 
11.84 
 
 
 
29 
 
 
 
1.699 
 
S* 
  
Post test 
 
S* Significant 
TABLE (4.4) shows the comparison between pre test and post test knowledge level 
regarding anticoagulant drug compliance among patients with mechanical heart valve. 
„t‟ test value was calculated using paired„t‟ test for difference of means. 
 In these, the mean difference was 7.37 with a SD of 3.41.The calculated „t‟test 
value was (11.84) which is higher than the table value (1.699). Therefore there is a 
significant difference between the mean pre test and post test level of knowledge 
score regarding anticoagulant drug compliance.     
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FIGURE 4.6 COMPARISON BETWEEN MEAN PRE TEST & POST TEST KNOWLEDGE SCORES ON ANTICOAGULANT 
DRUG COMPLIANCE  
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TABLE: 4.5 ASSOCIATION BETWEEN PRETEST KNOWLEDGE SCORE 
AND SELECTED DEMOGRAPHIC VARIABLES  
         n=30 
 
SI 
No 
 
Demographic variables 
Level of Knowledge Chi 
Square 
value 
Table 
Value 
5% 
Inadequate  
1-10 
Moderate 
11-15 
1 a) Age 
b) a. Below 30 yrs 
c) b.30-40 
d) c.41 -50 
e) d.51-60 
 
5 
7 
6 
1 
 
0 
4 
3 
4 
2=6.98 
df=3 
7.82 
NS* 
2 a) Sex 
b) a. Male 
c) b. Female 
 
6 
13 
 
4 
7 
2=0.071 
df=1 
3.84 
NS* 
3 a) Education 
b) a. Illiterate 
c) b. Primary 
d) c. Secondary 
e) d. High secondary 
f) f. Under graduate 
g) g. Post graduate 
 
3 
4 
7 
2 
2 
1 
 
5 
0 
4 
1 
0 
1 
2=5.94 
df=5 
11.07 
NS* 
4 a) Religion 
b) a.Hindu 
c) b.Muslim 
 
17 
2 
 
11 
0 
2=1.24 
df=1 
3.84 
NS* 
5 a) Type of family 
b) a.Nuclear family 
c) c.Joint family 
 
14 
5 
 
8 
3 
2=0.003 
df=1 
3.84 
NS* 
6 a) Occupation 
b) a.Unemployment 
c) b.Agriculture 
d) c.Government 
e) d.Private 
f) e.Others 
 
12 
4 
1 
2 
0 
 
4 
0 
0 
5 
2 
2=10.92 
df=4 
9.49 
S* 
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7 a) Family income 
b) a. Less than Rs10,000 
b.Rs 10,001-20,000 
15 
4 
10 
1 
2=0.717 
df=1 
3.84 
NS* 
8 a) Marital status 
b) a.Married 
c) b.Unmarried 
17 
2 
9 
2 
2=0.353 
df=1 
3.84 
NS* 
9 Previous history of any 
surgery 
a.Yes 
a) b.No 
11 
8 
8 
3 
2=0.660 
df=1 
3.84 
NS* 
10 Awareness of the 
anticoagulant drug prescribed 
a.Yes 
a) b.No 
0 
19 
3 
8 
2=5.757 
df=1 
3.84 
S* 
  NS* - Significant     S*- Significant 
  df     - Degrees of freedom 
Table (4.5) shows the association of pre test level of knowledge with demographic 
variables on anticoagulant drug compliance among patients with mechanical heart 
valve depicts the significance of association of pre test knowledge scores on 
anticoagulant drug compliance with demographic variables. It shows that the 
calculated chi square value of occupation is 10.929 at df = 4 and awareness of the 
anticoagulant drug prescribed is 5.757 at df = 1, significant at 0.05 level of 
significance.  There is no association between the pre test knowledge scores and 
demographic variables such as age, sex, education, religion, type of family, family 
income, marital status and previous history of surgery. 
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CHAPTER - V 
RESULTS AND DISCUSSION 
 The present study has been undertaken to identify the effectiveness of 
Structured Teaching Programme on Anticoagulant Drug Compliance among patients 
with Mechanical heart valve  
 The collected data for the present study was analyzed statistically and the 
results based on the objectives are discussed below: 
1. To assess the knowledge of patients with mechanical heart valve on 
anticoagulant drug compliance. 
  Table (4.2) results reveal that pre test 19 patients (63%) had inadequate knowledge, 
11 patients (37%) had moderate knowledge and no one had adequate knowledge. The 
mean score was 9.93 with a  SD of 2.71. 
Table (4.3) shows the post test level of knowledge on anticoagulant drug compliance 
among patients with mechanical heart valve. The results showed that in post test 
25(83.33%) patients had adequate knowledge, 5 (6.67%) patients had moderate 
knowledge and none had inadequate knowledge. The mean score post test was 17.3 
with a SD of 1.9. 
 Sara., et al (2011) conducted a cross-sectional study on 57patients. To 
determine the patients knowledge and adherence to oral anticoagulant drug therapy 
after mechanical heart-valve replacement surgery, for patients with congenital or 
acquired valve defects. Patient‟s knowledge was measured using the oral 
anticoagulation tool. A visual analogue scale was used to assess the adherence to 
therapy. Results revealed that most of the patients had lack of knowledge on oral 
anticoagulants, Three-quarters of patient‟s were 100% adherent to oral anticoagulant 
therapy, and about one fourth of the patients did not fully adhere to therapy. 
 Tang, EO., et al (2003) conducted a study to evaluate the patients‟ knowledge 
on warfarin and its relationship to anticoagulation control. 122 patients while 
attending warfarin clinic of prince of wale‟s hospital were interviewed. The 
knowledge on anticoagulant therapy and adherence to medical advice were tested 
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using 9 questions and found that patients' knowledge about warfarin was poor. 
Illiteracy was the main reason for not reading the booklet. Study found that there was 
a good correlation between patients' knowledge on warfarin and the international 
normalized ratio values and its target ranges. 
 The findings of the present study are in agreement with above cited studies 
which shows that patients prescribed with anticoagulant drug have lack of knowledge 
on anticoagulant drug compliance. 
2. To compare the pre test and post test knowledge level regarding anticoagulant 
drug compliance among patients with mechanical heart valve. 
Table (4.4) shows the comparison between pre test and post test knowledge level 
among patients with anticoagulants. In this the mean differences was 7.37 with a 
combined SD of 3.41 the calculated „t‟value (11.84) was higher than the table value 
(1.699) with the degrees of freedom 29; therefore there was a significant difference in 
pre test and post test level of knowledge. 
 Thanh., et al (2011) conducted a study to find the long-term effects of patient 
education program on oral anticoagulation therapy. In comparison to a patient 
information brochure, patients were selected and separated into two groups. 
Demographic data and knowledge on oral anticoagulation therapy was collected. 
Video was shown to participants on oral anti coagulation therapy. The video was 
based on scientific literature by trained nurses, and along with a brochure on aspects 
of anticoagulant therapy was provided for the interventional group. After 6weeks of 
blood work, the patients were assessed to fill the knowledge assessment 
questionnaire; the results showed that patient education program increases basic 
knowledge about oral anticoagulation therapy. 
 Khudair. (2010) conducted a cross-sectional study in the outpatient 
anticoagulation clinic to evaluate the patients' knowledge on warfarin, in a teaching 
hospital in Qatar. Self administered questionnaire was offered to patients taking 
warfarin for at least 2 months in patients who were attending the cardiology or 
medical anticoagulation clinics in General Hospital Hamad. Results showed that an 
integrated and multidisciplinary education program can improve the patient‟s 
knowledge on warfarin and its compliance. 
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 Thus the above cited studies support the present study which shows the 
effectiveness of structured teaching programme on anticoagulant drug compliance 
among patients with mechanical heart valve. 
3. To find the association between pre test knowledge score and selected 
demographic variables on anticoagulant drug compliance among patients with 
mechanical heart valves. 
Table (4.5) shows the association of the pre test level of knowledge with 
demographic variables on anticoagulant drug compliance among patients with 
mechanical heart valve. 
 Table shows the calculated value of occupation as 10.929 at df = 4 and 
awareness of the anticoagulant drug prescribed as 5.757 at df = 1, significant at 0.05 
level. Therefore occupation and awareness on anticoagulant drug prescribed has an 
association with the pre test knowledge score on anticoagulant drug compliance 
among patients with mechanical heart valve. 
   Table reveals that age, sex, education, religion, type of family, family 
income, marital status and previous history of surgery were not significant at 0.05 
levels. Therefore there was no association with pre test level of knowledge and 
demographic variables on anticoagulant drug compliance among patients with 
mechanical heart valve. 
 Sayeed., et al (2011) conducted a quasi-systematic review of the literature 
through electronic database searches, mainly to review the older patient‟s challenges 
in warfarin education in terms of knowledge. 62 articles were reviewed and found that 
increased patient knowledge result in better anticoagulation control. Demographic 
factors like advancing age, limited health literacy and lower family income, were 
found to be inversely affect patients‟ warfarin knowledge in different practice 
settings. And found that the demographic factors had mild association with patient‟s 
warfarin knowledge. 
 Hu, A., et al (2006) conducted a telephonic survey to find the influence of in-
hospital teaching practices as well as demographic variables and socioeconomic status 
on patients' knowledge about warfarin therapy. The knowledge of 100 patients were 
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assessed after 3 to 6months of mechanical heart valve surgery, using a 20 item tool. 
Demographic information‟s, such as socio economic status including educational 
status were collected and results revealed that sixty-one percent of participants had 
scores showing insufficient knowledge on warfarin therapy. Patient‟s age was not 
related to warfarin knowledge level. Patient‟s family income was greater than 
$25,000for those, who were employed or self-employed. The patients with education 
greater than grade 8, had a significantly higher knowledge scores on warfarin therapy. 
Variables like sex, race, and warfarin therapy before surgery were not associated to 
the level of knowledge on warfarin. 
 In the view of the above cited studies, comparison of pre test knowledge 
scores shows that there is a mild or negligible association between the level of 
knowledge on anticoagulant drug compliance and demographic variables. 
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CHAPTER - VI 
SUMMARY, CONCLUSION, NURSING IMPLICATIONS AND 
RECOMMENDATIONS 
This chapter represents the summary, finding, conclusion, implications and 
recommendations which create a base for researcher for evidence based practice. 
SUMMARY 
Extensive review of literature and expert‟s guidance led the researcher to 
design the methodology and the purpose of the study. The study was to assess the 
effectiveness of structured teaching programme on anticoagulant drug compliance 
among patients with mechanical heart valve in GKNM Hospital, Coimbatore 
Context evaluation, input evaluation, process evaluation and product evaluation 
(CIPP) theory was adopted for conceptual framework pre experimental one group 
pretest posttest design was selected for this study using the convenient sampling 
technique. Pilot study was conducted for nine days with six samples to assess the 
reliability and feasibility of the tool. The reliability was checked using the Spearman‟s 
split half method. 
The main study was conducted from 29.07.2013 to 24.08.2013.30 and 30 
samples were selected using the convenient sampling technique. Data collection was 
done for a period of four weeks. The pretest was conducted using the semi structured 
interview questionnaire to assess knowledge level on anticoagulant drug compliance 
among patients with mechanical heart valve. On the same day structured teaching 
programme on anticoagulant drug compliance was administered after which posttest 
was conducted on the day of discharge. The data collected was analyzed using both 
descriptive and inferential statistics. 
 The findings of the study revealed that structured teaching programme on 
anticoagulant drug compliance is effective in improving knowledge level of patients. 
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CONCLUSION 
 The findings of the study proved that patient‟s knowledge about anticoagulant 
drug compliance was inadequate and the structured teaching programme on 
anticoagulant drug compliance was effective in improving the knowledge level of 
patients about anticoagulant drug compliance. 
NURSING IMPLICATIONS 
 The findings of the study have implications for various areas of nursing 
practice, nursing education, nursing administration and nursing research 
Nursing Practice 
The role of nurses in patient education cannot be overlooked (Monsivais & 
Reynolds, 2003). 
 The nurse plays an important role in disease prevention & health promotion 
education program with effective strategies, which motivate the people to 
follow healthy practices in day to day life. Step should be taken to educate the 
patients to make them aware about anticoagulant drug compliance structured 
teaching programme once developed and evaluated to teach other groups of 
patients. 
 Structured teaching programme on anticoagulant drug compliance can be 
introduced as a routine programme for patients with mechanical heart valve in 
clinical areas. 
 Nurses can develop a positive attitude towards performance of structured 
teaching programme on anticoagulant drug compliance among patients with 
mechanical heart valve. 
 Nurses can help saving the lives of many by teaching and creating awareness 
on anticoagulant therapy in patients with mechanical heart valve. 
 Nurses can develop Evidence Based Practice and include structured teaching 
programme on anticoagulant drug compliance among patients with mechanical 
heart valve as a routine teaching programme. 
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Nursing Education 
Findings of present study have an implication in nursing education. 
 The curriculum of student nurses should include the importance of 
anticoagulants for patients with mechanical heart valve 
 The nurse educator must be able to assess the  student nurses knowledge 
regarding anticoagulant drug compliance 
 The nurse educator should arrange continue nursing education for staff nurses 
by regularly updating their knowledge on anticoagulant drugs and its 
compliance. 
Nursing Administration 
 The findings of present study will help nurse administrators to organize and 
plan for various programmes to provide immediate teaching for patients about 
awareness on anticoagulant drugs after mechanical heart valve replacement surgery 
 Nurse administrator can plan in service education / continue nursing education 
programs regarding anticoagulant drug and its compliance for  mechanical 
heart valve replacement patients 
 Arrangement of an exclusive nurse specialist who can collaborate with the 
multidisciplinary team, in order to support and educate awareness of 
anticoagulants on mechanical heart valve replacement patients. 
 Nurse administrator should implement outreach programs to make the public 
aware. 
Nursing Research 
 The present study is an attempt to assess the effectiveness of structured 
teaching programme on anticoagulant drug compliance among patients with 
mechanical heart valve. 
 Nursing research on importance of anticoagulant drug compliance will be a 
valuable reference material for further researchers. 
 Qualitative study can be undertaken to assess the self report of the 
participants. 
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RECOMMENDATIONS 
This study recommends the following for further research 
 The study can be conducted with large sample size. 
 Similar study can be conducted with a qualitative approach. 
 A similar study can be undertaken to a different population in different 
settings. 
 A similar study can be done using a different method of teaching the 
importance of anticoagulant drug among patients with mechanical heart valve. 
 A similar study can be conducted to compare different methods of teaching the 
importance of anticoagulant drug among patients with mechanical heart valve. 
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APPENDIX – C1 
DATA COLLECTION TOOL 
STRUCTURED INTERVIEW GUIDE 
SECTION A: DEMOGRAPHIC PROFILE 
       INSTRUCTIONS:      SAMPLE NO: 
 Please give appropriate response to the following statements 
 The information obtained will be kept confidential and is used only for the 
intended work. 
1. Age 
a) Below 30 yrs 
b) 31-40 yrs 
c) 41-50 yrs 
d) 51-60 yrs 
e) 61-70 yrs 
f) Above 70 yrs 
2. Sex 
a) Male 
b) Female 
3. Education 
a) Illiterate 
b) Primary 
c) Secondary 
d) Higher secondary 
e) Under graduate 
f) Post graduate 
4. Religion 
a) Hindu 
b) Christian 
c) Muslim 
d) Others 
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5. Type of family 
a) Nuclear family 
b) Joint family 
6. Occupation 
a) Unemployment 
b) Agriculture 
c) Business 
d) Medical 
e) Government 
f) Private 
g) Others 
7. Family income 
a) Less than 10,000 Rs 
b) 10,001-20,000 Rs 
c) 20,001-30,000 Rs 
d) Above 30,000 Rs 
8. Marital status 
a) Married 
b) Unmarried 
9. Previous history of any surgery 
a) Yes 
b) No 
10. Are you aware of the anticoagulant drug prescribed? 
a) Yes 
b) No 
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SECTION B: STRUCTURED KNOWLEDGE INTERVIEW 
QUESTIONNAIRE 
1. How many liters of blood is available in adult body ? 
a. 1 - 5 liters 
b. 4 - 6 liters 
c. 6 - 8 liters 
d. 9 - 10 liters 
2. Which vitamin helps the blood to clot ? 
a. Vitamin A 
b. Vitamin D 
c. Vitamin E 
d. Vitamin K 
3. What is the sample taken for checking clotting time? 
a. Urine 
b. Blood 
c. Sputum 
d. Motion 
4. What is the duration for the blood to clot ? 
a. 0 -  2 mts 
b. 1  - 3 mts 
c. 5  -  10 mts 
d. 15 - 30 mts 
5. What is the name of the investigation for checking the blood clotting? 
a. Prothrombin time  
b. Packed cell volume  
c. Complete  blood count  
d. Bilirubin  test  
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6. What is the normal value of Prothrombin time? 
a. 5.5-10 sec 
b. 11.5-18 sec 
c. 12.5-20 sec 
d. 18.5-20 sec 
7. How often is your Prothrombin test to be done after heart valve replacement? 
a. Once in a week 
b. Once in a month 
c. Once in 3 months 
d. Once in a year 
8. What is the action of anti coagulant drug? 
a. Makes blood thicker 
b. Makes blood thinner 
c. Prevent bleeding 
d. Prevent infection 
9. Where will you store anticoagulants? 
a. Refrigerator 
b. Under direct sunlight 
c. Dry place 
d. Cool place 
10. What is the best time to take anticoagulant drug? 
a. Lunch time -12pm 
b. Evening  - 6pm 
c. Morning  - 6am 
d. Any time of the day 
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11. How long are you expected to take anticoagulants after surgery? 
a. 1 year 
b. 1 month 
c. Depends on the type of  heart valve replaced 
d. Life long 
12. What will you do if you forget to take your anticoagulant tablet? 
a. Skip the dose 
b. Take the tablet as soon as you remember 
c. Take two doses of tablet 
d. Take ½ the tablet 
13. What are the symptoms due to less dose of anticoagulant drug? 
a. Slurring of speech and stroke 
b. Difficulty in breathing 
c. Unconsciousness 
d. All of the above 
14. What are the symptoms due to overdose of anticoagulant drug? 
a. Bleeding gums 
b. Bloody or red colour urine 
c. Red  or black stools 
d. All  of the above 
15. What is the most common sideffects of anticoagulant drug? 
a. Tendency to bleed easily 
b. Chest pain 
c. Head ache 
d. Fainting spells 
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16. What are the activities to be avoided while on anti coagulants 
a. Straining while defecation 
b. Cuts and falls 
c. Gardening & sewing 
d. All of the above 
17. What are the first aid measures to be done while bleeding? 
a. Wash with running water 
b. Apply pressure 
c. Elevate the affected area 
d. All of the above 
18. How to maintain the body weight when on anti coagulant drug? 
a. Increase the weight 
b. Decrease the weight 
c. Maintain constant body weight 
d. Variable body weight 
19. When is it necessary to inform to other physicians and dentist about the intake of 
anticoagulants? 
a. Inform before the treatment 
b. Not necessary to inform 
c. Inform during the treatment 
d. Inform after the complication occurs 
20. What are the life style modifications to be followed while on anticoagulant drug? 
a. Stop smoking & drinking 
b. Stop smoking 
c. Stop drinking 
d. Stop fast foods 
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ANSWER KEY 
Scoring procedure 
Each correct response gets a score of one (1). There are 20 items and hence the 
maximum score for  the knowledge questions is 20 
Q.NO ANSWER Q.NO ANSWER 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
b. 
d. 
b. 
c. 
a. 
b. 
c. 
b. 
c. 
b. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
d. 
a. 
d. 
d. 
a. 
d. 
d. 
c. 
a. 
a. 
SCORING AND INTERPRETATION 
 
Level of knowledge 
 
Score 
 
Percentage 
Adequate 0-10 50 % 
Moderate 11-15 51-75 % 
Inadequate 16-20 76-100 % 
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APPENDIX – C2 
STRUCTURED INTERVIEW GUIDE – TAMIL 
tbtikf;fg;gl;l NeHKff;fhzy; tpdhj;jhs;-M 
Ra rKf; Fwpg;G 
 Nfl;Fk; Nfs;tpfSf;F rupahd tpilaspf;fTk; 
 ePq;fs; nfhLf;Fk; tpguq;fs; ufrpakhf ghJfhf;fg;gLk; 
1. taJtuk;G 
1) 30 taJf;F fPo; 
2) 31-40 tiu 
3) 41-50 tiu 
4) 51-60 tiu 
5) 61-70 tiu 
6) 71 taJf;F Nky; 
2. ,dk; 
1) Mz; 
2) ngz; 
3. gbg;G 
1) gbf;fhjtu; 
2) Muk;gf;fy;tp 
3) ,ilepiyf;fy;tp 
4) Nky;epiyf;fy;tp 
5) ,sepiyf;fy;tp 
6) KJepiyf;fy;tp 
4. kjk; 
1) ,e;J 
2) K];ypk; 
3) NtW kjq;fs; 
5. FLk;g mikg;G 
1) jdpf; FLk;gk; 
2) $l;Lf; FLk;gk; 
6. njhopy; 
1) Ntiy ,y;iy 
2) tptrhak; 
3) Ra njhopy; 
4) kUj;Jtk; 
xi 
 
5) muR gzpahsu; 
6) jdpahu; gzpahsu; 
7) NtW tifahd njhopy;fs; 
7. khj tUkhdk; 
1) U 10000 f;F fPo;    
2) U 10001-20000 tiu 
3) U 20000-30000 tiu 
8. jpUkzj; jFjp 
1) jpUkzkhdtu; 
2) jpUkzkhfhjtu; 
9. Ke;ja mWit rpfpr;ir 
1) Mk; 
2) ,y;iy 
10. ,uj;j ciw jLg;G kUe;ij gw;wp Nfs;tpg;gl;bUf;fpwPu;fsh?  
1) Mk; 
2) ,y;iy 
 
tbtikf;fg;gl;l NeHKfffhzy; tpdhj;jhs;-M 
1. kdpj clypy; Rkhh; vj;jid ypl;lh; ,uj;jk; cs;sJ? 
m) 1 – 5 ypl;lh; 
M) 4 – 6 ypl;lh; 
,) 6 – 8 ypl;lh; 
<) 9 – 10 ypl;lh; 
2. ve;j itl;lkpd; ,uj;j ciwjYf;F cjTfpwJ?  
m) itl;lkpd; - v 
M) itl;lkpd; - b 
,) itl;lkpd; - , 
<) itl;lkpd; - Nf 
3. ,uj;jk; ciwjYf;fhd Neuj;ij fz;L gpbf;f nra;ag;gLk; Nrhjidf;F 
gad;gLj;jg;gLk; khjphp vd;d? 
m) rpWePh; 
M) ,uj;jk;  
,) rsp  
<) kyk; 
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4. ,uj;jk; ciwjYf;F vLj;Jf; nfhs;sg;gLk; Neuk; vd;d? 
m) 0 – 2 tpehbfs; 
M) 1 – 3 tpehbfs; 
,) 5 – 10 tpehbfs; 
<) 15 – 30 tpehbfs; 
5. ,uj;jk; ciwjYf;fhd Neuj;ij fz;Lgpbf;f nra;ag;gLk; Nrhjidapd; 
ngah; vd;d? 
m) GNuhj;uhk;gpd; Neu Nrhjid 
M) Ngf; nry; njhFjp 
,) KO ,uj;j vz;zpf;if 
<) gpyp&gpd; Nrhjid 
6. GNuhj;uhkpd; Neu Nrhjidapd; rhpahd msT vd;d? 
m) 5.5 – 10 nehbfs; 
M) 1.5 – 18 nehbfs; 
,) 12.5 – 20 nehbfs; 
<) 18.5 – 20 nehbfs; 
7. ,Uja thy;T khw;W mWit rpfpr;irapd;  gpwF GNuhj;uhk;gpd; Nrhjid 
vg;nghOnjy;yhk; nra;a Ntz;Lk;? 
m) thuj;jpw;F xU Kiw 
M) khjj;jpw;F xU Kiw 
,) %d;W khjj;jpw;F xU Kiw 
<) tUlj;jpw;F xUKiw 
8. ,uj;jk; ciwjLg;G kUe;jpd; Ntiy vd;d? 
m) ,uj;jj;ij fl;bahf;FfpwJ 
M) ,uj;jj;ij nkypjhf;FfpwJ 
,) ,uj;jf;frpit jLf;fpwJ 
<) Neha; njhw;iw jLf;fpwJ 
9. ,uj;j ciw jLg;G kUe;ij ve;j ,lj;jpy; gj;jpug;gLj;jp itf;fyhk;? 
m) Fsph;rhjdg; ngl;b 
M) #hpa xspapd; fPo; 
,) cyh;e;j ,lk; 
<) Fsph;e;j ,lk; 
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10. ,uj;j ciw jLg;G kUe;ij vLg;gjw;fhd rhpahd Neuk; vd;d? 
m) kjpa cztpw;F gpd; – 12 kzpastpy; 
M) khiy – 6 kzp  
,) fhiy – 6 kzp  
<) ve;j Neuj;jpYk; 
11. ,Uja thy;T mWit rpfpr;irf;Fg; gpwF ,uj;j ciw jLg;G kUe;ij 
vt;tsT fhyk; vLf;f Ntz;Lk;? 
m) xU tUl msT 
M) xU khj msT  
,) ,Uja thy;T tifia rhh;e;jJ 
<) tho;ehs; KOtJk; 
12. ,uj;j ciwjLg;G kUe;ij vLf;f jtwptpl;lhy; vd;d nra;tPh;fs;? 
m) vLf;f jtwpa khj;jpiuia tpl;LtpLyhk; 
M) epidT te;jTld; khj;jpiuia vLj;Jf;nfhs;syhk; 
,) ,uz;L khj;jpiufs; vLj;Jf; nfhs;syhk;. 
<) miu khj;jpiu vLj;Jf; nfhs;syhk; 
13. ,uj;j ciw jLg;G kUe;jpd; msT Fiwtjhy; Vw;gLk; mwpFwpfs;  
vd;d? 
m) Ngr;Rf;Fswy; kw;Wk; gf;fthjk; 
M) %r;Rj;jpzwy; 
,) Raepidtpd;ik 
<) Nkw;$wpa midj;Jk; 
14. ,uj;j ciw jLg;G kUe;jpd; msT mjpfhpg;gjhy; Vw;gLk; mwpFwpfs; 
vd;d? 
m) <Wfspy; ,uj;jf;frpT 
M) rptg;G epw rpwePh; 
,) rptg;G my;yJ fWg;G kyk; 
<) Nkw;$wpa midj;Jk; 
15. ,uj;j ciwjLg;G kUe;J cl;nfhs;Sk; NghJ Vw;gLk; gpd;tpisTfs; 
vd;d? 
m) vspjhf ,uj;jk; frpa tha;g;G 
M) neQ;Rtyp 
,) jiytyp 
<) kaf;fk; 
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16. ,uj;j ciwjLg;G kUe;J cl;nfhs;Sk; NghJ jtph;f;f Ntz;ba 
nray;fs; vd;d 
m) kyk; fopf;Fk; NghJ rpukg;gLtJ 
M) ntl;Lf;fhaq;fs; kw;Wk; fPNo tpOjy; 
,) Njhl;l Ntiy kw;Wk; ijay; Ntiy 
<) Nkw;$wpa midj;Jk; 
17. ,uj;jf;frpT Vw;GLk; NghJ nra;a Ntz;ba KjYjtp vd;d? 
m) XLk; ePhpy; fhaj;ij fOtTk; 
M) fhaj;jpy; mOj;jk; nfhLf;fTk; 
,) fhak; Vw;gl;l ,lj;ij cah;j;jp itf;fTk; 
<) Nkw;$wpa midj;Jk; 
18. ,uj;j ciwjLg;G kUe;J vLj;Jf; nfhs;Sk; NghJ vt;thW clypd; 
vilia guhkhpf;fyhk;? 
m) vilia mjpfhpj;jy; 
M) vilia Fiwj;jy; 
,) epiyahd cly; vil 
<) epiyaw;w cly; vil 
19. ,uj;j ciwjLg;G kUe;J cl;nfhs;Stij gw;wp gy; kUj;jth; kw;Wk; 
kw;w kUj;Jth;fsplk; vg;nghOJ njhptpf;f Ntz;Lk; 
m) rpfpr;irf;F Kd; 
M) njhptpf;f mtrpakpy;iy 
,) rpfpr;irapd; NghJ 
<) gpd; tpisTfs; Vw;gl;l gpwF 
20. ,uj;j ciwjLg;G kUe;J cl;nfhs;Sk; NghJ vd;ndd;d tho;f;if Kiw 
khw;wq;fis fil gpbf;f Ntz;Lk;? 
m) Gif kw;Wk; Fbgof;fj;ij jtph;j;jy; 
M) Gifg;gof;fj;ij jtph;j;jy; 
,) Fbg;gof;fj;ij jtph;j;jy; 
<) Jhpj czTfis jtph;j;jy; 
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APPENDIX-D1 
INTERVENTION IN ENGLISH 
STRUCTURED TEACHING PROGRAMME ON ANTICOAGULANT DRUG 
COMPLIANCE 
Place    : Cardio thoracic wards of GKNM Hospital 
Group     : Patients with mechanical heart valves on anticoagulant drug 
therapy 
Method of teaching : Lecture cum Discussion 
A.V aids  : Power point slides 
Educator  : Ms. Jenifer. D 
INTRODUCTION 
 I am IIyear M.Sc(N) Student of G. Kuppusamy Naidu Memorial Hospital, 
Institute  of Nursing, Coimbatore. Now I am going to discuss about Heart, Heart 
valves, Blood coagulation, Laboratory investigations done for mechanical heart valve 
patients, Anticoagulant drug, Dosage, Importance of drug, side effects, precautions 
and Lifestyle modification for patients taking anticoagulants. 
HEART 
 Heart is a hollow muscular organ, the heart pumps blood to the tissues 
supplying oxygen and nutrients. An adult human body has about 4-6 liters of blood. 
There are four heart valves in a healthy human heart. The valves help to maintain 
proper blood flow through the heart, keeping blood moving efficiently and smoothly, 
and in the right direction, if the valves get narrow or leak, if the valves are diseased 
beyond repair they need to be replaced. Replacement can be done by artificial valves; 
 Artificial valves are classified in to two groups 
1) Biological valves   : derived from human or animal source. 
2) Mechanical valves :  derived from metal or plastic. 
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ARTIFICIAL VALVES: 
 Artificial valves are in direct contact with blood. Blood exposed to any 
artificial material can clot. Blood clots can block an artery or a vein (blood vessels). A 
blocked artery stops blood and oxygen from getting to a part of the body (for 
example, to a part of the heart, brain or lungs). The tissue supplied by a blocked artery 
becomes damaged, or dies, and this results in serious problems such as a stroke. 
BLOOD COAGULATION: 
  Within seconds of cutting a blood vessel, the damaged tissue causes platelets 
(tiny cells in the blood) to become sticky and clump together around the cut. These 
activated platelets and the damaged tissue release chemicals which react with other 
chemicals and proteins in the blood, called clotting factors. Naturally the vitamin K 
helps the blood to clot in Human body. 
LABORATORY INVESTIGATION: 
  An anticoagulant helps the body to control how fast your blood clots; 
therefore, it prevents clots from forming inside your arteries, veins or heart. The effect 
of anticoagulants must be monitored carefully with blood testing. On the basis of the 
results of the blood test, daily dose of anticoagulant will be adjusted to keep clotting 
time within a target range. The blood test used to measure the time it takes for blood 
to clot is referred to as prothrombin time test, or protime (PT).The normal value of 
Prothrombin time is 11.5-18sec. The PT is reported as the International Normalized 
Ratio(INR). 
 The INR ensures that PT results obtained by different laboratories can be 
compared. It is important to monitor the INR (at least once a month and sometimes as 
often as twice weekly) to make sure that the level of warfarin remains in the effective 
range. The normal INR range in patients taking warfarin is 2.0-3.0, if the INR is too 
low, blood clots will not be prevented, but if the INR is too high, there is an increased 
risk of bleeding. This is why those who take anticoagulant must have their blood 
tested frequently. Once the dose of anticoagulant is stabilized the Prothrombin test 
can be done once in three months. Go to the same laboratory each time. 
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ANTICOAGULANTS: 
 Anticoagulants are medicines that prevent the blood from clotting as quickly 
or effectively as normal, and makes the blood thinner, So that the blood does not clot 
over the artificial valve. They act by blocking Vitamin K which is essential for normal 
clotting. 
STORAGE: 
 Keep this medication in dry place at room temperature, and out of reach of 
children, away from excess heat, moisture and light. Throw away any medication that 
is outdated or no longer needed.  
DOSAGE: 
 Dosage of anticoagulant needs to be adjusted, Depending on the type of valve 
replaced.Some people need to take it for a few weeks (after surgery) or months (deep 
vein thrombosis).some people need to take an anticoagulant for the rest of their lives. 
 You should aim to take anticoagulants at the same time each day. This is 
usually six o'clock in the evening. 
 The medication can be taken after food.  
 If you accidentally miss a dose, NEVER take a double dose, Skip it, Take the 
dose as instructed once a day. If you forget to take your dose and remember 
within 8 hours, take the dose. If it is past 8 hours, wait until the next day and 
take only the prescribed dose for that day. DO NOT TAKE A DOUBLE 
DOSE.  
 If you forget two or more days in a row, call your doctor. The dose may need 
to be changed.  
 When you take the dose, check off the day on your home calendar, or Diary. 
 A timely reminder (telephone) of follow-up visits can be provided. 
 Refill your prescription 1 week before the end of your supply to avoid missing 
a dose.  
 Continue to take warfarin (Coumadin) as long as your doctor prescribes it (life 
long). 
 Carry an identification card or wear a bracelet stating that you take 
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anticoagulants, List your name, medical problems, medications dosages, 
doctor's name and telephone number on the card. 
 If an accident occurs and you are too ill to communicate, a medical alert tag 
will help responders  to provide appropriate care.  
 Do not let anyone else to take your medication.  
 It is important for you to keep a written list of all of the prescription and 
nonprescription (over-the-counter) medicines you are taking. 
The Lowering  dose of anticoagulant causes: 
 change in intensity of valve sounds 
 Difficulty in Breathing 
 Unconsciousness’ or Giddiness 
 Limb weakness or Stroke 
 Slurring of Speech 
Symptoms of overdose may include the following: 
 Higher dose can make the blood too thin cause bleeding.  
 Bloody or red, or tarry bowel movements 
 Spitting or coughing up blood 
 Heavy bleeding with your menstrual period 
 Pink, red, or dark brown urine 
 Coughing up or vomiting material that looks like coffee grounds 
 Small, flat, round red spots under the skin  
 Unusual bruising or bleeding 
 Continued oozing or bleeding from minor cuts 
The common side effect of anticoagulant drug is the tendency to bleed easily. 
If any of the following serious bleeding side-effects occur while taking an 
anticoagulant, see a doctor urgently and have a blood test: 
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THE FIRST AID MEASURE TO BE DONE FOR MINOR BLEEDING: 
 Wash with running water 
 Apply pressure on the bleeding area. 
 Elevate the affected area. 
 If bleeding does not stop by itself consult the Doctor. 
SIMPLE MEASURES TO DECREASE THE RISK OF BLEEDING WHILE 
TAKING ANTICOAGULANTS INCLUDES THE FOLLOWING:  
 Use a soft-bristled toothbrush 
 Floss with waxed floss rather than unwaxed floss 
 Shave with an electric razor rather than a blade 
 Take care when using sharp objects, such as knives and scissors 
 Try to avoid insect bites. Use a repellent when you are exposed to insect bites. 
 Avoid activities that have a risk of falling or injury (e.g., contact sports) 
 Avoid straining while defecation 
 Avoid Gardening and Sewing. 
GUIDELINES TO FOLLOW WHILE TAKING MEDICATIONS: 
 Avoid grapefruit and cranberry products.  
 If you eat spinach, turnip greens, other leafy greens, broccoli, Brussels sprouts, 
kale, parsley, liver, or green tea, be sure to eat a consistent amount week to 
week.  
 Eat all other foods as you normally would.  
 Tell your doctor if you are thinking about changing your current eating habits. 
Tell your doctor if you are planning to:  
 Eat more or less vegetables.  
 Change to a vegetarian style of eating. 
PROSTHETIC HEART VALVE INFECTION:- 
 Any foreign body placed inside the body is subject to the possibility of 
becoming infected. Certain precautions should be taken to reduce risk. Any fever that 
was experienced should be reported to your physician. Any prolonged incident (more 
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than two or three days) of sinusitis or upper respiratory symptoms such as a cold or 
flu should be reported to physician. Remind him/her that you have a prosthetic heart 
valve. He/she may conduct tests to rule out prosthetic heart valve infection. You can 
minimize the chance of infection occurring by keeping all your physicians informed 
that you have a heart valve prosthesis implanted. Inform dentist, before any dental 
procedure carries the risk of infecting prosthesis. Dentist will prescribe an important 
antibiotic treatment prior to dental appointments, which helps to avoid infection. 
LIFE STYLE MODIFICATIONS: -   
WEIGHT: Avoid gaining Weight while on anticoagulants, it increases the drug dose 
requirement and makes heart to strain.      
 ALCOHOL: Alcohol intake can affect how the body metabolizes anticoagulants. 
Patients taking anticoagulants should avoid alcoholic beverages such as beer and 
wine, according to the Agency for Healthcare and Research Quality, Alcohol 
increases the risk of gastrointestinal bleeding in patients taking anticoagulants. Signs 
of gastrointestinal bleeding include vomits that look like coffee grounds, dark stool, 
coughing blood, abdominal tenderness, weakness and dizziness.  
SMOKING: Stop smoking. It can affect the action of anticoagulants. 
EXERCISE: Check with your doctor before starting any exercise or sports program.  
TRAVEL: Check with your healthcare provider if you expect to travel. While 
traveling, it is important to carry your medication with you at all times. Do not put 
medication into checked baggage 
SUMMARY AND CONCLUSION:- 
 So far we have discussed about the heart, heart valves, Blood coagulation, 
Laboratory investigation, Anticoagulants, storage, dosage, symptoms of over dose & 
lower dose, first aid measures to be done for bleeding and Life style modifications for 
patients with mechanical valve taking anticoagulants. Thank You. 
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APPENDIX-D2 
INTERVENTION IN TAMIL 
,uj;j ciw jLg;G kUe;J gw;wpa tbtikf;fg;gl;l Nghjid Kiw ghljpl;lk; 
Kd;Diu:- 
tzf;fk; ehd; [p. Fg;GRthkp ehAL epidT kUj;Jtkid nrtpypah; 
fy;Y}hapy; vk;.v];.rp gapYk; khztp ,g;nghOJ ehd; cq;fsplk; 
$wg;NghtjhtJ ,Ujak;> ,Ujathy;Tfs;> ,uj;j ciwjy;> khw;W thy;T 
nghUj;jgl;lth;fSf;F nra;ag;gLk; Ma;tf ghpNrhjid> ,uj;j ciw jLg;G 
kUe;J> mjd; msT> mk;kUe;jpd; Kf;fpaj;Jtk;> gpd;tpisTfs;> mij 
jLg;gjw;fhd topKiwfs;> kw;Wk; ,uj;j ciw jLg;G kUe;ij 
cl;nfhs;gth;fs; nra;a Ntz;ba tho;f;if Kiw khw;wq;fs; 
MfpaitfshFk;. 
,Ujak;:- 
,Ujak; vd;gJ jirfshy; Md xU cWg;G. ,UjakhdJ RUq;fp 
tphpe;J clYf;F Njitahd ,uj;jj;ij nfhLf;fpwJ. ,jd; %ykhf clypd; 
nry;fs; Mf;rp[d; kw;Wk; Cl;lr;rj;Jf;fis ngw;Wf;nfhs;fpwJ. xU ruhrhp 
kdpjdpd; clypy; Rkhh; 4 – 6 ypl;lh; ,uj;jk; cs;sJ. ,ja thy;Tfs; 
rhpahd Kiwapy; ,uj;j Xl;lj;ij ghukhpf;f cjTfpwJ. ,J ,uj;j 
Xl;lj;ij rPuhfTk; rhpahd jpirapYk; nry;y cjTfpwJ.  
,ja thy;Tfspy; Neha; Vw;gl;lhy; thy;Tfspy; RUf;fNkh my;yJ 
frpNth Vw;gLk;> gOJghh;j;Jk; rhpahfhj epiyapy; mWit rpfpr;ir nra;J 
thy;it khw;w Ntz;Lk;. ,jw;F nraw;if thy;Tfs; gad;gLj;jg; gLfpwJ   
mit ,uz;L tifgLk;. 
1. caphpay; thy;Tfs; kdpj my;yJ tpyq;FfsplkpUe;J ngwg;gLfpd;wd 
2. nkf;fhdpf;fy; thy;Tfs; gpsh];bf; my;yJ cNyhfj;jpypUe;J 
ngwg;gLfpd;wd 
nraw;if thy;Tfs; /khw;W thy;Tfs;  :- 
khw;wgl;l ,jathy;Tfs; ,uj;j Xl;lj;Jld; neUq;fpa njhlh;G 
nfhz;Ls;sd. ve;j nraw;if nghUSlDk; ,uj;jk; njhlh;G nfhz;lhy; 
,uj;jk; ciwa tha;g;G cz;L. ,J ,uj;jfl;bfshf khwp ,uj;j ehsq;fis 
milf;fyhk;. vg;gFjpapy; milg;G Vw;gl;Ls;sNjh mg;gFjpf;F ,uj;jk; kw;Wk; 
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Mf;]p[d; fpilg;gJ epd;W Ngha; tpLfpwJ (v.fh.) EiuaPuy;> %is kw;Wk; 
,Ujaj;jpd; xUgFjp ,jdhy; mg;gFjpapy; cs;s jpRf;fs; gOjile;Njh 
my;yJ ,we;Njh Ngha; tpLtjhy; gf;fthjk; Nghd;w fLikahd gpur;ridfs; 
Vw;gLfpwJ. ,it capUf;F Mgj;jhdit. 
,uj;jk; ciwjy;:- 
,uj;j ehsq;fspy; fhak; Vw;gl;l xU rpy tpdhbfSf;Fs;NsNa 
Nrjkile;j jpRthdJ ,uj;jjl;Lfis xd;whfTk; xl;Lk; jd;ikAilajhfTk; 
khw;wp fhakile;j ,lj;ij #o;e;J nfhs;s nra;fpwJ. ,e;j ,lj;jpy; ,uj;j 
jl;Lfs; kw;Wk; fhakile;j jpRf;fs; xUtpjkhd Ntjpg; nghUis 
ntspapLfpwJ. ,e;j NtjpnghUs; ,uj;jj;jpy; kw;w Ntjp nghUl;fSld; Nrh;e;J 
,uj;j ciwjiy cz;lhf;FfpwJ. ,JNt ,uj;j ciwjYf;fhd fhuzpfs; 
vdg;gLfpwJ. ,aw;ifahfNt ekJ clypy; itl;lkpd; “Nf” ,uj;j 
ciwjYf;F cjTfpwJ. 
Ma;tf ghpNrhjid:- 
 ,uj;j ciw jLg;G kUe;J ,uj;j ciwjiy jLg;gjhy; clypy; 
cs;s rpiufs;> jkdpfs; kw;Wk; ,jaj;jpy; ,uj;jk; ciwtij jLf;fpwJ. 
,uj;j ciw jLg;G kUe;jpd; tpisit ,uj;j ghpNrhjid nra;tjd; %ykhf 
kpfTk; ftdkhf fz;fhzpf;f Ntz;Lk;. ,uj;j ghpNrhjid  Kbtpd; 
mbg;gilapy; ,uj;j ciwjYf;fhd Neuj;ij rhpahd mstpy; itj;J 
nfhs;tjw;fhf jpdrhp vLj;J nfhs;sg;gLk; ,uj;j ciw jLg;G kUe;jpd; 
msit khw;wp mikf;fyhk;. ,uj;jk; ciwtjw;fhf vLj;J nfhs;Sk; 
Neuj;jpd; msit msg;gjw;fhf nra;ag;gLk; ghpNrhjidNa GNuhNjhuk;gpd; Neu 
Nrhjid Mjd; rhpahd KbT 11.5-18  tpdhb MFk;. ,uj;j ghpNrhjid 
KbTfis rPuhf;f jukhd ghpNrhjid $lq;fs; KbTfis I .vd; .Mh; vd;w 
msT Nfhyhy; Fwpf;fpd;wd. I vd; Mh; vd;gJ ,d;lh; Ne\dy; ehh;kiy];L 
Nu];Nah> ,uj;j ciw kUe;ij vLf;Fk; egUf;fhd rhpahd KbT 2.0 – 3.0 
nehbfs; I vd; Mh; d; msT kpf Fiwthf ,Uf;Fk; NghJ ,uj;j ciwjy; 
Vw;gLfpwJ. Mdhy; kpf mjpfkhf ,Uf;Fk;NghJ ,uj;jf; frpT Vw;gLtjw;fhd 
tha;Tfs; mjpfhpf;fpwJ. vdNt jhd; ,uj;j ciw jLg;G kUe;ij vLf;Fk; 
egh; mbf;fb ,uj;j ghpNrhjid nra;Jnfhs;tJ kpfTk; mtrpakhd xd;whf 
$wg;gLfpwJ. clYf;F Njitahd khj;jpiuapd; msTk; ,uj;j ghpNrhjid 
KbTk;, rkepiy vl;ba gpd;dh; ghpNrhjid %d;W khjj;jpw;F xU Kiw 
nra;jhy; NghJkhdJ. xNu ghpNrhjid $lj;jpy; ghpNrhjid nra;J nfhs;tJ 
ey;yJ. 
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,uj;j ciw jLg;G kUe;J: 
 ,uj;j ciw jLg;G kUe;J ,uj;jk; ,aw;ifahf ciwtij 
jLg;gJld; ,uj;jj;jpd; jputepiyia NkYk; ,yFthf;FfpwJ. ,jdhy; 
nraw;if thy;Tfspy; ,uj;j ciwjy;; Vw;gLtjpy;iy mj;Jld; ,J ,uj;j 
ciwjYf;F cjTk; tpl;lkpd; Nf apd; nray;ghl;ilAk; jLf;fpwJ. 
ghJfhj;J itj;jy;:- 
 ,e;j kUe;ij miwntg;gepiyapy; cyh;e;j ,lj;jpYk; Foe;ijfSf;F 
vl;lhjthW mjpf msT ntg;gk; <ug;gjk; kw;Wk; xsp ,y;yhj 
,lj;jpYk; ghJfhg;ghf itf;f Ntz;Lk;. 
 fhyhtjpahd ve;j kUe;JfisAk; gad;gLj;j$lhJ 
,uj;j ciw jLg;G kUe;jpd; rhpahd msT:- 
 khw;wpaikf;fg;gl;l thy;tpw;F Vw;wthW ,uj;j ciwjYf;fhd kUe;ij 
rhpnra;J nfhs;s Ntz;Lk;. 
 xU rpyh; jq;fSila tho;ehs; KOtJk; ,e;j kUe;ij vLj;Jnfhs;s 
Ntz;Lk;.  
 ePq;fs; ,uj;j ciw khj;jpiuia xt;nthU ehSk; Fwpg;gpl;l mNj 
Neuj;jpy; tof;fkhf vLj;Jf; nfhs;s Ntz;Lk;. tof;fkhf khiy MW 
kzpf;F vLj;J nfhs;syhk;.  
 cztpw;Fgpd; khj;jpiuia cl;nfhs;s Ntz;Lk;. ePq;fs; jw;nrayhf 
khj;jpiuia vLj;Jf; nfhs;sj; jtwptpl;lhy; md;iwa ehSf;Fhpa 
khj;jpiuia tpl;L tpl Ntz;Lk;. 
 kWehs; jtwpa khj;jpiuAk; Nrh;e;J vLj;Jf; nfhs;s $lhJ. xU 
ehisf;nfd;W ghpe;Jiuf;fgl;l khj;jpiuNa xU ehisf;F 
vLj;Jf;nfhs;s Ntz;Lk;.  
 khj;jpiuia rhg;gpl kwe;j vl;L kzpNeuj;jpw;Fs; Qhgfk; te;jhy;    
clNd khj;jpiuia vLj;Jf; nfhs;syhk; Mdhy; ,uz;L                                                                                                                                                                                                                                                                                                                                                                                                         
khj;jpiuahf rhg;gpl $lhJ. 
 ,uz;L my;yJ ,uz;L ehl;fSf;F Nky; ePq;fs; khj;jpiuia vLf;f 
jtwptpl;lhy; cldbahf cq;fs; kUj;Jtiu mZf Ntz;Lk;. 
 kUj;Jth; khj;jpiuapd; msit khw;wpaikf;fyhk;.  
 ePq;fs; jpdrhp kUe;J vLj;Jf; nfhs;Sk; NghJ fhy ml;ltizapNyh 
my;yJ ilhpapNyh Fwpj;Jf; nfhs;s Ntz;Lk;. 
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 khj;jpiufs; vLf;f jtwptplhky; ,Ug;gjw;F cq;fs; khj;jpiufs; 
jPu;e;J Nghtjw;F 1 thuj;jpw;F Kd;djhfNt Njitahd khj;jpiufis 
thq;fp itj;J nfhs;s Ntz;Lk; 
 cq;fsJ kUj;Jth; ghpe;Jiuj;j ehs; tiuf;Fk; ,uj;j ciwjLg;G 
khj;jpiuia njhlh;e;J vLf;f Ntz;Lk;. 
 ,uj;j ciwjLg;G khj;jpiuia vLj;Jf;nfhs;Sk; egh; milahs 
ml;ilNah ifapy; mzpAk; fhg;igNah vg;nghOJk; jq;fSld; 
itj;Jf; nfhs;s Ntz;Lk;. 
 mjpy; mtuJ ngah; kUj;Jt gpur;ridfs; khj;jpiuapd; ngah; kw;Wk; 
msT kUj;Jthpd; ngah; kw;Wk; njhiyNgrp vz; Nghd;wtw;iw 
Fwpj;Jf; nfhs;s Ntz;Lk;. 
 VNjDk; tpgj;J Vw;gl;lhy; me;Neuj;jpy; ,e;j ml;il cjtpahf 
mikAk;. 
 cq;fsJ khj;jpiuia kw;wtw;fs; vLg;gjw;F mDkjpf;ff; $lhJ 
 cq;fsJ kUj;Jth; ghpe;Jiue;j khj;jpiufspd; gl;baiyAk; ePq;fs; 
tof;fkhf vLf;Fk; khj;jpiufspd; gl;baiyAk; ftdkhf itj;J 
nfhs;s Ntz;Lk;. 
khj;jpiuapd; msT Fiwtjhy; Vw;gLk; mwpFwpfs;:- 
 khw;W thy;T Vw;gLj;Jk; rj;jk; Fiwjy; 
 %r;R tpLjypy; rpukk; jiy Rw;wy; 
 kaf;fk; (m) Raepidtpoj;jy; 
 iffhy; jsh;r;rp kw;Wk; nraypog;G 
 Ngr;R Fswy;                                           
khj;jpiuapd; msT mjpfhpg;gjhy; Vw;gLk; mwpFwpfs;:- 
 khj;jpiuapd; msT $bdhy; ,uj;jj;jpd; jpuTepiy mjpfupf;fpwJ 
,jdhy; ,uj;jf; frpT Vw;gLfpwJ 
 rpfg;G (m) fWg;G epw kyk; fopj;jy; 
 vr;rpy; (m) ,Ukypd; NghJ ,uj;jk; tUjy; 
 khjtplhapy; mjpf ,uj;j Nghf;F 
 rpfg;G (m) fWg;G epw rpWePh;  
 fhg;gp epw the;jp vLj;jy; 
 rpwpa jl;ilahd tl;lkhd rptg;G Gs;spfs; NjhYf;F mbapy; 
fhzg;gLjy; 
 rpwpa ntl;Lfhaq;fspy; ,Ue;J njhlh; ,uj;jfrpT 
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 mrhjuzkhd ,uj;j frpT kw;Wk; ,uj;j ciw jLg;G kUe;J 
vLg;gjhy; nghJthf ,uj;j frpT Nghd;w gf;f tpisTfs; Vw;gl 
tha;g;Gfs; cs;sd. 
 ,uj;j ciwjLg;G kUe;J vLf;Fk; NghJ Nkw;$wpa mwpFwpfs; VNjDk; 
Njhd;wpdhy; cldbahf kUj;Jtiu mZfp ,uj;j ghpNrhjid nra;a 
Ntz;Lk;. 
rpwpa fhaq;fspy; ,Ue;J Vw;gLk; ,uj;jf;frpit epWj;j nra;ag;gLk; 
KjYjtp:- 
 fhak; Vw;gl;l ,lj;ij XLk; ePhpy; fOt Ntz;Lk; 
 ed;F mOj;jk; nfhLf;f Ntz;Lk; 
 fhak; Vw;gl;l ,lj;ij cah;j;jp itf;f Ntz;Lk; 
 ,e;j KjYjtpapd; gpd; ,uj;jf; frpTnjhlu;e;J Vw;gl;lhy; kUj;Jtiu 
mZf Ntz;Lk;. 
,uj;j ciwjLg;G kUe;Jfis vLj;Jf; nfhs;Sk; nghOJ ,uj;jf;frpit 
jLg;gjw;fhd rpy vspa topKiwfs;:- 
 nkd;ikahd euk;Gfs; cs;s gy;Jyf;fpia gad;gLj;Jjy;  
 kopj;njLj;j gy;Fj;jp %yk; gw;fspd; <Wfis Rj;jk; nra;aTk; 
 gpNsil gad;gLj;jp rtuk; nra;tij tpl kpd;rhu Nu]h; nfhz;L rtuk; 
nra;aTk; 
 fj;jp kw;Wk; fj;jphpNfhy; Nghd;w $h;ikahd nghUl;fis ftdkhf 
ifahs Ntz;Lk; 
 nfhRf;fs; Nghd;w  G+r;rpfbfis jtph;f;f jLg;G Kiwfis ifahs 
Ntz;Lk; 
 fPNo tpOjy; kw;Wk; fhak; Vw;gLjiy jtph;f;f Ntz;Lk; 
 rpukg;gl;L kyk; fopj;jiy jtph;f;f Ntz;Lk; 
 Njhl;l Ntiy kw;Wk; ijay; Ntiyfis jtph;f;f Ntz;Lk; 
,uj;j ciwjLg;G kUe;ij vLf;Fk; NghJ ifahs Ntz;ba czTg; 
gof;ftof;fq;fs;:- 
 jpuhl;irg;gok; kw;Wk; FUjpney;yp czTg; nghUl;fis jtph;f;f 
Ntz;Lk;  
 fPiutiffs;> Kisfl;ba gapW> Kl;ilNfh];> Ks;sq;fp> gr;ir 
fha;fwpfs;> fy;yPuy; kw;Wk; gr;ir Njapiy Nghd;witfis xNu 
mstpy; cl;nfhs;s Ntz;Lk;. 
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 cq;fs; jw;Nghija czT gof;fKiwia khw;w  tpUk;gpdhy; 
cq;fs; kUj;Jthplk; njhptpf;f Ntz;Lk; 
 tof;fkhf rhg;gpLk; czTfis vg;nghOJk; Nghy; vLj;Jf; 
nfhs;syhk; 
 Fiwe;j msNth my;yJ mjpf msNth gr;irf; fha;fwpfs; 
cl;nfhz;lhy; mijAk; kUj;Jthplk; $wTk; 
 irt czTg; gof;fj;ij filgplbf;fTk;  
nraw;if thy;T (Neha;) fpUkp jhf;Fjy;:- 
 clk;gpDs; ve;j tpjkhd nraw;if nghUl;fs; itf;fg;gLk; NghJk; 
fpUkpfs; jhf;Ftjw;fhd tha;g;G cs;sJ. ,ij jLg;gjw;F xU rpy 
topKiwfis Nkw;nfhs;s Ntz;Lk;. ve;j tpjkhd fha;rypdhNyh (m) 
rspgpbj;jy; Nghd;w %r;RFoha; njhlh;Gila NehapdhNyh ghjpf;fgl;lhy; 
cldbahf kUj;Jtiu mZfTk;. mk;kUe;Jthplk; cq;fSf;F nraw;if 
thy;T nghUj;jg;gl;bUg;gij njhptpf;fTk;. ,jd; %yk; nraw;if thy;tpy; 
Neha; fpUkp jhf;fpAs;sjh vd;W ghpNrhjid nra;J fz;lwpa KbAk;. 
Fwpg;ghf cq;fSf;F nraw;if thy;T nghUj;jg;gl;bUg;gij ve;jtpj gy; 
rpfpr;irf;F Kd;Gk; gy; kUj;Jthplk; njhptpg;gJ mtrpak;. ,jd; %yk; 
fpUkpfs; thy;it ghjpf;fhjpUf;f Ez;Zapu; nfhy;ypfs; Nghd;w kUe;Jfis 
ghpe;Jiug;ghh;. 
tho;f;if Kiw khw;wq;fs;:- 
cly; vil : ,uj;j ciw jLg;G kUe;J cl;nfhs;Sk; nghOJ msTf;F 
mjpfkhf vil $bdhy; ,Ujaj;jpd; nray;ghl;by; rpukk; Vw;gLk; 
khj;jpiuapd; NjitAk; mjpfhpf;Fk;. 
kJ mUe;Jjy; : kJ mUe;JtJ ,uj;j ciw jLg;G kUe;jpd; nray;ghl;il 
ghjpf;fpwJ vdNt kJ mUe;Jtij jtph;f;;f Ntz;Lk;. kJ mUe;Jgtu; ,uj;j 
ciw jLg;G kUe;jpid cl;nfhs;Sk; NghJ czT Fohapy; ,uj;jfrpT 
Vw;gLtjw;fhd tha;g;G mjpfKs;sJ. czTf; Fohapy; ,uj;j frptpdhy; 
Vw;gLk; mwpFwfshtd the;jp (fhg;gp epwk;)> fWg;G epw kyk;> ,uj;jj;Jld; 
$ba rsp> tapw;Wtyp> gytPdk;> kaf;fk;. 
Gifgpbj;jy : Gifgpbg;gij jtph;f;f Ntz;Lk;>Gif gpbj;jy; ,uj;j ciw 
jLg;G kUe;jpd; nray;ghl;bid jLf;Fk;. 
clw;gapw;rp : ve;j tpjkhd tpisahl;LfisNah (my;yJ) clw;gapw;rpiaNah 
Jtq;Ftjw;F Kd; kUj;Jthpd; MNyhrid ngw Ntz;Lk;. 
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gazk; : ePz;l J}u gazj;jpw;F Kd; kUe;Jthpd; MNyhrid ngw;W 
nfhs;tJld; cq;fsJ kUe;Jfis cld;vLj;J nry;tJ kpf mtrpak; 
Kbtiu:                                   
 ,Jtiu ehk; ,Ujak; ,Uja thy;Tfs; nraw;if thy;Tfs; ,uj;j 
ciwjy; ,uj;j ciw jLg;G kUe;ij cl;nfhs;gth;fs; nra;a Ntz;ba 
Ma;tf ghpNrhjid kw;Wk; mk;kUe;jpd; msT Kf;fpaj;Jtk; ,uj;jj;jpy; 
mk;kUe;jpd; msT mjpfhpg;gjhNyh my;yJ FiwtjhNyh Vw;gLk; mwpFwpfs; 
,uj;jfrpT Vw;gLk; NghJ nra;a Ntz;ba KjYjtp nraw;if  thy;T 
nghUj;jg;gl;L ,uj;j ciw jLg;G kUe;J cl;nfhs;gth;fs; filgpbf;f 
Ntz;ba tho;f;if Kiwfs; gw;wp ,Jtiu ghu;j;Njhk;. ed;wp. 
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